WO2004032808A2 - Devices and methods for mixing and extruding medically useful compositions - Google Patents
Devices and methods for mixing and extruding medically useful compositions Download PDFInfo
- Publication number
- WO2004032808A2 WO2004032808A2 PCT/US2003/031691 US0331691W WO2004032808A2 WO 2004032808 A2 WO2004032808 A2 WO 2004032808A2 US 0331691 W US0331691 W US 0331691W WO 2004032808 A2 WO2004032808 A2 WO 2004032808A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- container
- chemically reactive
- substance
- syringe
- opening
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 120
- 238000000034 method Methods 0.000 title claims abstract description 78
- 238000002156 mixing Methods 0.000 title claims abstract description 68
- 239000000126 substance Substances 0.000 claims abstract description 141
- 108090000190 Thrombin Proteins 0.000 claims description 73
- 229960004072 thrombin Drugs 0.000 claims description 73
- 108010049003 Fibrinogen Proteins 0.000 claims description 56
- 102000008946 Fibrinogen Human genes 0.000 claims description 56
- 229940012952 fibrinogen Drugs 0.000 claims description 56
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 54
- 239000011707 mineral Substances 0.000 claims description 54
- 239000000316 bone substitute Substances 0.000 claims description 41
- 239000003292 glue Substances 0.000 claims description 40
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 33
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 33
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 claims description 27
- 239000000463 material Substances 0.000 claims description 27
- 239000002131 composite material Substances 0.000 claims description 26
- 239000007788 liquid Substances 0.000 claims description 23
- 239000011575 calcium Substances 0.000 claims description 21
- 229910052791 calcium Inorganic materials 0.000 claims description 21
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 12
- 102000008186 Collagen Human genes 0.000 claims description 12
- 108010035532 Collagen Proteins 0.000 claims description 12
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 12
- 229920001436 collagen Polymers 0.000 claims description 12
- 239000003431 cross linking reagent Substances 0.000 claims description 11
- 230000002051 biphasic effect Effects 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 8
- 238000007710 freezing Methods 0.000 claims description 8
- 230000008014 freezing Effects 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 7
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 6
- 229920002101 Chitin Polymers 0.000 claims description 6
- 229920002261 Corn starch Polymers 0.000 claims description 6
- 229920002085 Dialdehyde starch Polymers 0.000 claims description 6
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 6
- 239000005057 Hexamethylene diisocyanate Substances 0.000 claims description 6
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 6
- 239000008120 corn starch Substances 0.000 claims description 6
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 claims description 6
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims description 6
- 238000003032 molecular docking Methods 0.000 claims description 6
- 239000006174 pH buffer Substances 0.000 claims description 6
- 239000000661 sodium alginate Substances 0.000 claims description 6
- 235000010413 sodium alginate Nutrition 0.000 claims description 6
- 229940005550 sodium alginate Drugs 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 5
- 239000011800 void material Substances 0.000 claims description 4
- 230000008859 change Effects 0.000 claims description 3
- 239000007795 chemical reaction product Substances 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 5
- 150000002500 ions Chemical group 0.000 claims 5
- 239000011780 sodium chloride Substances 0.000 claims 5
- 239000013543 active substance Substances 0.000 claims 2
- 239000008187 granular material Substances 0.000 description 64
- 229950003499 fibrin Drugs 0.000 description 38
- 108010073385 Fibrin Proteins 0.000 description 32
- 102000009123 Fibrin Human genes 0.000 description 32
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 32
- 239000000243 solution Substances 0.000 description 26
- 210000000988 bone and bone Anatomy 0.000 description 23
- 238000001125 extrusion Methods 0.000 description 19
- 239000004568 cement Substances 0.000 description 11
- -1 polyethylene Polymers 0.000 description 10
- 230000007547 defect Effects 0.000 description 9
- 238000003825 pressing Methods 0.000 description 9
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- 238000006116 polymerization reaction Methods 0.000 description 8
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 7
- 239000001110 calcium chloride Substances 0.000 description 7
- 229910001628 calcium chloride Inorganic materials 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 238000012384 transportation and delivery Methods 0.000 description 7
- 239000000872 buffer Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 239000001506 calcium phosphate Substances 0.000 description 5
- 229910000389 calcium phosphate Inorganic materials 0.000 description 5
- 235000011010 calcium phosphates Nutrition 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- 108010071289 Factor XIII Proteins 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 239000013256 coordination polymer Substances 0.000 description 4
- 230000009977 dual effect Effects 0.000 description 4
- 229940012444 factor xiii Drugs 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 238000001878 scanning electron micrograph Methods 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 239000000017 hydrogel Substances 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 239000004570 mortar (masonry) Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 230000000379 polymerizing effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- 229920001651 Cyanoacrylate Polymers 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 230000000881 depressing effect Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000000399 orthopedic effect Effects 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000000565 sealant Substances 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- BTOTXLJHDSNXMW-POYBYMJQSA-N 2,3-dideoxyuridine Chemical compound O1[C@H](CO)CC[C@@H]1N1C(=O)NC(=O)C=C1 BTOTXLJHDSNXMW-POYBYMJQSA-N 0.000 description 1
- MBEVSMZJMIQVBG-UHFFFAOYSA-N 2-(hydroxymethyl)guanidine Chemical compound NC(N)=NCO MBEVSMZJMIQVBG-UHFFFAOYSA-N 0.000 description 1
- CQVWXNBVRLKXPE-UHFFFAOYSA-N 2-octyl cyanoacrylate Chemical compound CCCCCCC(C)OC(=O)C(=C)C#N CQVWXNBVRLKXPE-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 1
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 102000005755 Intercellular Signaling Peptides and Proteins Human genes 0.000 description 1
- 108010070716 Intercellular Signaling Peptides and Proteins Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
- 239000006057 Non-nutritive feed additive Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000013566 Plasminogen Human genes 0.000 description 1
- 108010051456 Plasminogen Proteins 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 206010052779 Transplant rejections Diseases 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- OIRDTQYFTABQOQ-UHTZMRCNSA-N Vidarabine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O OIRDTQYFTABQOQ-UHTZMRCNSA-N 0.000 description 1
- 229960004150 aciclovir Drugs 0.000 description 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229960003805 amantadine Drugs 0.000 description 1
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 229940034982 antineoplastic agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 229940125687 antiparasitic agent Drugs 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 229940121357 antivirals Drugs 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000000227 bioadhesive Substances 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 239000007767 bonding agent Substances 0.000 description 1
- 229940112869 bone morphogenetic protein Drugs 0.000 description 1
- 230000010478 bone regeneration Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 239000007931 coated granule Substances 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 238000005056 compaction Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 239000002619 cytotoxin Substances 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229940063123 diflucan Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000005429 filling process Methods 0.000 description 1
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000002241 glass-ceramic Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 238000007210 heterogeneous catalysis Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000002159 nanocrystal Substances 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 230000000278 osteoconductive effect Effects 0.000 description 1
- XDRYMKDFEDOLFX-UHFFFAOYSA-N pentamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCCCOC1=CC=C(C(N)=N)C=C1 XDRYMKDFEDOLFX-UHFFFAOYSA-N 0.000 description 1
- 229960004448 pentamidine Drugs 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000011295 pitch Substances 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 230000002345 thrombinlike Effects 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- 229960003962 trifluridine Drugs 0.000 description 1
- VSQQQLOSPVPRAZ-RRKCRQDMSA-N trifluridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(C(F)(F)F)=C1 VSQQQLOSPVPRAZ-RRKCRQDMSA-N 0.000 description 1
- 102000003390 tumor necrosis factor Human genes 0.000 description 1
- 229960003636 vidarabine Drugs 0.000 description 1
- 210000000605 viral structure Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 229960002555 zidovudine Drugs 0.000 description 1
- HBOMLICNUCNMMY-XLPZGREQSA-N zidovudine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-XLPZGREQSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
- A61B17/88—Osteosynthesis instruments; Methods or means for implanting or extracting internal or external fixation devices
- A61B17/8802—Equipment for handling bone cement or other fluid fillers
- A61B17/8805—Equipment for handling bone cement or other fluid fillers for introducing fluid filler into bone or extracting it
- A61B17/8816—Equipment for handling bone cement or other fluid fillers for introducing fluid filler into bone or extracting it characterised by the conduit, e.g. tube, along which fluid flows into the body or by conduit connections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
- A61B17/88—Osteosynthesis instruments; Methods or means for implanting or extracting internal or external fixation devices
- A61B17/8802—Equipment for handling bone cement or other fluid fillers
- A61B17/8833—Osteosynthesis tools specially adapted for handling bone cement or fluid fillers; Means for supplying bone cement or fluid fillers to introducing tools, e.g. cartridge handling means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00491—Surgical glue applicators
- A61B2017/00495—Surgical glue applicators for two-component glue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
- A61B17/88—Osteosynthesis instruments; Methods or means for implanting or extracting internal or external fixation devices
- A61B17/8802—Equipment for handling bone cement or other fluid fillers
- A61B17/8833—Osteosynthesis tools specially adapted for handling bone cement or fluid fillers; Means for supplying bone cement or fluid fillers to introducing tools, e.g. cartridge handling means
- A61B2017/8838—Osteosynthesis tools specially adapted for handling bone cement or fluid fillers; Means for supplying bone cement or fluid fillers to introducing tools, e.g. cartridge handling means for mixing bone cement or fluid fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/46—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
- A61F2/4601—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for introducing bone substitute, for implanting bone graft implants or for compacting them in the bone cavity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2002/2817—Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00179—Ceramics or ceramic-like structures
- A61F2310/00293—Ceramics or ceramic-like structures containing a phosphorus-containing compound, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
- A61F2310/00377—Fibrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2048—Connecting means
- A61J1/2058—Connecting means having multiple connecting ports
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2068—Venting means
- A61J1/2075—Venting means for external venting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2096—Combination of a vial and a syringe for transferring or mixing their contents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/1782—Devices aiding filling of syringes in situ
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/19—Syringes having more than one chamber, e.g. including a manifold coupling two parallelly aligned syringes through separate channels to a common discharge assembly
Definitions
- This invention relates to medical devices for mixing and extruding medically useful compositions, such as those used as bone replacement materials.
- Bone replacement materials typically are composed of a mineral component and a glue that surrounds and binds the mineral component. Often the mineral component is a calcium based mineral, and the glue component is a fibrin glue. The fibrin glue is formed by mixing fibrinogen and thrombin components.
- Bone replacement material is typically mixed using a mortar and pestle and then applied as a paste.
- the mortar and pestle method often destroys or greatly compromises the integrity of the fibrin glue matrix. This is due to the mechanical grinding action associated with using the mortar and pestle.
- Other similar methods involve mixing of the components on a flat surface using a spatula or like implements.
- Another disadvantage of current methods of mixing bone replacement materials is that they do not provide for final mixtures wherein the component parts are distributed homogeneously and in precise quantities.
- the present invention provides devices and methods for mixing and extruding compositions which are medically and non-medically useful.
- the device is particularly useful for mixing substances which are relatively inert when alone but become reactive when mixed.
- a common feature of all of the devices is that they allow the user to mix and ultimately extrude a composition from a single device which includes a single container or multiple interconnected containers.
- the device comprises a chamber which contains a mineral component and a glue component.
- the device further provides a member associated with the chamber for delivering a reaction product of the mineral and the glue.
- the device has a first container having a first opening which is adapted to contain a first chemically reactive substance.
- the device further includes a second container having a second opening which is adapted to contain a second chemically reactive substance and a third container have a third opening.
- a connector that connects the first opening, second opening, and third opening is provided such that the first chemically reactive substance and the second chemically reactive substance can travel through the connector and through the third opening into the third container to form a composition.
- a member is provided for extruding the composition from the third container.
- the device in another embodiment, includes a first container having a first opening which is adapted to contain a first chemically reactive substance.
- the device further includes a second container having a second opening which is adapted to contain a second chemically reactive substance.
- a connector is provided that connects the first opening and second openings such that the first chemically reactive substance can travel through the connector and through the second opening into the second container wherein the first and second chemically reactive substances can react to form a composition.
- the device further includes means for extruding the composition from the second container.
- the device includes a syringe.
- the syringe has a hollow cylindrical tube with a forward opening, and a rear opening through which a piston is fitted.
- the forward opening is fitted such that a removable cap can cover the forward opening.
- the removable cap contains a removable cover that covers a port into which a luer tip can be inserted.
- the present invention further provides a method for mixing and extruding a bone replacement material.
- the method comprises the steps of providing a device comprising at least one container wherein at least two components of the bone replacement material are mixed and extruded after mixing; placing the components of the bone replacement material into the device; mixing the components to form the bone replacement material; and extruding the bone replacement materials from the device.
- the method comprises the steps of providing a syringe having a hollow cylindrical tube with a forward opening, and a rear opening through which a piston is fitted; the forward opening being fitted such that a removable cap can cover the forward opening; and the removable cap containing a removable cover that covers a port into which a luer tip can be inserted; placing at least two chemically reactive substances in the tube; causing the substances to react to form a composition; and extruding the composition from the tube.
- the method comprises the steps of providing a syringe having a hollow cylindrical tube with a forward opening, and a rear opening through which a piston is fitted; the forward opening being fitted such that a removable cap can cover the forward opening; and the removable cap containing a removable cover that covers a port into which a luer tip can be inserted; placing a first reactive substance in the tube and freezing the first reactive substance; placing a second non-reactive substance on top of the first reactive substance and freezing the tube again, placing a second reactive substance on top ofthe non- reactive substance and freezing the tube, sublimating the non-reactive substance during the freezing process leaving a void between the first and second reactive substances, aspirating water in the tube causing the first and second substance to react to form a composition; and extruding the composition from the tube.
- the method comprises the steps of providing a syringe having a hollow cylindrical tube with a forward opening, and a rear opening through which a piston is fitted; the forward opening being fitted such that a removable cap can cover the forward opening; and the removable cap containing a removable cover that covers a port into which a luer tip can be inserted, placing a first reactive component into the syringe, placing a second reactive component into the syringe; and mixing the first and second components together, whereby the first and second reactive components mix to form a composition without any change in total volume.
- FIG. 1 illustrates a schematic view of a device ofthe present invention.
- FIG. 2 illustrates a schematic view of another device ofthe present invention.
- FIG. 3 illustrates a schematic view of yet another device ofthe present invention.
- FIGS. 4a-c illustrate perspective views of yet another device of the present invention featuring a cap which has a luer tip that can be moved into a docking position.
- FIG. 5 is a scanning electron micrograph of a cross-section of a sample of bone replacement material mixed and extruded using a device ofthe present invention.
- FIG. 6 is a scanning electron micrograph of a cross-section of an additional sample of bone replacement material mixed and extruded using a device ofthe present invention.
- the substances When mixed, the substances can form a desired composition that is medically or non- medically useful.
- a common thread among the devices ofthe present invention is that they allow the practitioner to mix and ultimately extrude the desired composition from a single device that comprises a single container or multiple interconnected containers.
- the device can be used for mixing macroporous biphasic calcium phosphate (MBCP) or any calcium based mineral with fibrin or non fibrin glues.
- MBCP macroporous biphasic calcium phosphate
- the devices can be used for mixing MBCP or a calcium based mineral with biological fluids or a liquid such as water, buffer, jelling agent, corn starch, or the like.
- the devices of the present invention can mix MBCP or a calcium based mineral with a polymer or copolymer such as polyethylene, polypropylene, PLA, PGA, polyvinyl alcohol, polymethyl methacrylate, or silicone. It is further possible to use the present invention to mix a non- calcium based mineral such as SiO2 based glasses or glass ceramic with fibrin glues, non- fibrin glues, biological fluid including cells or a liquid as described above.
- a polymer or copolymer such as polyethylene, polypropylene, PLA, PGA, polyvinyl alcohol, polymethyl methacrylate, or silicone.
- a non- calcium based mineral such as SiO2 based glasses or glass ceramic with fibrin glues, non- fibrin glues, biological fluid including cells or a liquid as described above.
- the devices ofthe present invention can be used to mix virtually any substances that yield a useful product, the inventor contemplates that such devices are especially beneficial for mixing and delivering compositions that are used for the replacement, repair and augmentation of mammalian bone structures.
- HA Hydroxyapatite
- MBCP Hydroxyapatite
- MBCP is a biocompatible substance that has defined mechanical and osteoconductive properties as well as the capability to bond adjacent hard and soft tissues.
- a major problem in the reconstruction of a bone defect with hydroxyapatite granules is the instability, dislocation and migration of the granules from the cavity.
- orthopedic surgeons often mix the MBCP granules with a two-component fibrin glue.
- the main advantage is the application of the implant as a moldable paste that prevents dislocation of the granules, maintaining the required bulk and shape during the tissue ingrowth.
- the common components of bone repair material are often therefore a granular mineral component that is surrounded by a glue component.
- the glue component is typically a mixture of at least two chemically reactive components.
- commercially available fibrin glues include BERIPLAST® from Aventis Behring, BIOCOL® from LFB, BOHELAL® from Kaketsuken, QUIXILTM from Omrix , HEMASEEL® from Hemacure.
- home made glues are known from automated systems such as VrVOSTATTM, CRYOSEAL®, AUTOSEAL TM and BIOCORAL®, as well as synthetic cyanoacrylate based glues such as DERMABOND®, LIQUIDERMTM SOOTHE-N-SEALTM, all available from Closure, INDERMILTM from Locite, LIQUIDBAND® from MedLogic, and GLUBRAN® from GEM.
- automated systems such as VrVOSTATTM, CRYOSEAL®, AUTOSEAL TM and BIOCORAL®
- synthetic cyanoacrylate based glues such as DERMABOND®, LIQUIDERMTM SOOTHE-N-SEALTM, all available from Closure, INDERMILTM from Locite, LIQUIDBAND® from MedLogic, and GLUBRAN® from GEM.
- non-fibrin glues and non-synthetic products such as FLOSEAL® from Fusion Medical Technologies, COSEALTM from Cohesion, FOCALSEAL® from Focal, as well as plasma derivative sealants such as FIBRXTM from Cryolife, and non-sintered hydroxyapatite with crystalline nanoparticulate such as OSTIMTM.
- FLOSEAL® from Fusion Medical Technologies
- COSEALTM from Cohesion
- FOCALSEAL® FOCALSEAL® from Focal
- plasma derivative sealants such as FIBRXTM from Cryolife
- OSTIMTM non-sintered hydroxyapatite with crystalline nanoparticulate
- OSTIMTM non-sintered hydroxyapatite with crystalline nanoparticulate
- Fibrin glues can be used as bonding agents to adhere to and around the mineral component of a bone replacement material. Fibrin sealants/glues are well-known in the art for use in haemostasis, tissue sealing and wound healing and have been commercially available for more than a decade. Fibrin glues imitate the last step of the blood coagulation cascade and are usually commercialized as kits comprising two main components. The first component is a solution comprising fibrinogen and factor XIII, while the second component is a thrombin-calcium solution. After mixing of components, the fibrinogen is proteolytically cleaved by thrombin and thus converted into fibrin monomers.
- Factor XIII is also cleaved by thrombin into its activated form (FXIIIa). FXffla cross-links the fibrin monomers to a three-dimensional network commonly called "Fibrin Matrix.”
- the components of the fibrinogen and thrombin can be prepared from plasma by conventional precipitation and purification steps.
- human plasma will be preferred.
- the source ofthe plasma may be either pooled donor blood or single donor blood obtainable from blood centers, respectively. Care should be taken that state of the art controls are performed to detect viral contamination.
- the products may be sterilized by standard techniques as well.
- the components could be prepared from pre- operative autologous blood donation. It will be understood that the components ofthe first or the second solution or their functional analogues may also be prepared by using the methods of molecular genetics.
- two- component fibrin glue kits may be used for the preparation of the fibrin film of the present invention.
- the required constituents are usually contained in the kits in the form of lyophilized concentrates and have to be reconstituted as per the technical data sheet provided with the respective kit.
- the desired thrombin concentration is prepared by diluting an aliquot of the reconstituted thrombin solution with sterile calcium chloride solution, preferably 20 mM or 40 inM calcium chloride or the appropriate buffer that maintains the ionic strength of the solution.
- the inventors propose that the fibrin glue used in connection with the present invention may also be obtained from one vial containing all the required components.
- the catalytic agents for the fibrinogen-fibrin conversion and the cross-linking of soluble fibrin, respectively, are inactivated and the polymerization is only started by induction through a change in pH, ionic strength, exposure to light or the like after the content of said vial had been applied to a solid support.
- photo-sensitive inhibitors of thrombin and thrombin-like molecules could be used for this purpose.
- the fibrin glue ofthe invention may also be prepared in accordance with Copley and Luchini, (Life Sciences 3, 1293-1305, 1964) and Sasaki et al. (Science 152, 1069-1071, 1966) by starting from soluble fibrinogen-fibrin monomer complexes precipitated in the cold, redissolved at high temperature and which are then cross-linked with factor XIII and calcium.
- jelling agents such as hydroxypropylmethylcellulose, carboxylmethylcellulose, chitosan may be used to improve washout resistance before hardening of the cement occurs as described in the J. Res. Natl. Inst. Stand.Technol.l 06, 1029-1033 (2001).
- the bone replacement material can also include the addition of self assembling amphiphile peptides designed to mimic aggregated collagen fibers (extracellular matrices) and also form supramolecular networks. A subset of this family can also be engineered to nucleate hydroxyapatite nanocrystals to serve as artificial extracellular matrice for bone regeneration as disclosed in J. D. Hartgerink, E. Beniash, and S. I. Stupp: Self- Assembly and Mineralization of Peptide- Amphiphile Nanofibers, Science, 294, (5527) 1684 (2001).
- a fibrinogen solution preferably contains fibrinogen and factor XIII (10-40 IU/mL).
- the concentration of fibrinogen is expressed as the total protein concentration (preferably from about 15-140 mg/mL and more preferably 30-110 mg/mL) and the percentage of clottable protein contained therein.
- the fibrinogen solution have a viscosity that allows the solution to be manipulated using pressures generated using a hand-operated syringe.
- the fibrinogen solution should have a viscosity of less than 300 centipoise, more preferably less than 100 centipoise, and most preferably from 5-50 centipoise or any combination or subcombination of ranges therein.
- the inventors prefer the percentage of clottable protein to be at least 80% and preferably equal to or greater than 90%.
- the thrombin solution preferably has a concentration from about 0.01 IU/mL to about 10,000 IU/mL, even more preferably from about 200 to about 500 IU/mL, and most preferably from about 400 to about 500 IU/mL or any combination or subcombination of ranges therein (depending on the desired biophysical parameters of the material to be obtained) and calcium in a concentration of up to 45 mM.
- the thrombin concentration normally given in IU/mL will in the following frequently be indicated in IU.
- hydrogels are know in the art and can be mixed using the devices and methods ofthe present invention.
- hydrogels include those prepared in accordance with U.S. Patent Application Serial No. 09/566,019, which is hereby incorporated by reference.
- cross-linked hydrogels and bioadhesives such as those described in U.S. Patent Nos. 6,066,325; 6,063,061; and 6,007,613, all of which are incorporated herein by reference, can also be used with the devices and methods of the present invention.
- Other chemically reactive substances can be used as the glue-like component to bind to and around the mineral component of the bone replacement substance.
- Such other substances can include, for example, sodium alginate and calcium chloride, collagen and a cross-linking agent such as low pH buffer, chitin, formaldehyde, glutaraldehyde, dialdehyde starch, hexamethylene diisocyanate and certain polyepoxy compounds.
- a cross-linking agent such as low pH buffer, chitin, formaldehyde, glutaraldehyde, dialdehyde starch, hexamethylene diisocyanate and certain polyepoxy compounds.
- suitable cross-linking agents are disclosed in U.S. Patent No. 6,165,489.
- Collagen compositions can be prepared in accordance with U.S. Patent No. 4,061,787, which relates to formable collagen compositions including cross-linking agents and U.S. Patent No. 5,643,464, which relates to collagen with a sterile, dry cross-linking agent.
- Alginate compositions include those described in U.S. Patent No. 6,39
- the glue component can additionally include components such as, for example, hardeners, cross- linking agents, pigments, processing aids (such as lubricant, plastifying agent, surfactant, viscosity reducing agent, etc.), fibers, polymers, copolymers, antibody, antimicrobial agent, agent for improving the biocompatibility of the structure, proteins, anticoagulants, anti- inflammatory compounds, compounds reducing graft rejection, living cells, cell growth inhibitors, agents stimulating endothelial cells, antibiotics, antiseptics, analgesics, antineoplastics, polypeptides, protease inhibitors, vitamins, cytokine, cytotoxins, minerals, interferons, hormones, polysaccharides, genetic materials, proteins promoting or stimulating the growth and/or
- Drugs which may be used in accordance with the present invention include, but are not limited to, antimicrobial compositions, including antibiotics, such as tetracycline, ciprofloxacin, and the like; antimycogenic compositions; antivirals, such as gangcyclovir, zidovudine, amantidine, vidarabine, ribaravin, trifluridine, acyclovir, dideoxyuridine, and the like, as well as antibodies to viral components or gene products; antifungals, such as diflucan, ketaconizole, nystatin, and the like; and antiparasitic agents, such as pentamidine, and the like.
- antibiotics such as tetracycline, ciprofloxacin, and the like
- antimycogenic compositions such as gangcyclovir, zidovudine, amantidine, vidarabine, ribaravin, trifluridine, acyclovir, dideoxyuridine, and the like, as well as antibodies
- the drugs may further include anti-inflammatory agents, such as .alpha.- or .beta.- or .gamma.- interferon, .alpha.- or beta.- tumor necrosis factor, and the like, and interleukins.
- anti-inflammatory agents such as .alpha.- or .beta.- or .gamma.- interferon, .alpha.- or beta.- tumor necrosis factor, and the like, and interleukins.
- the glue component can be mixed with a mineral component to form a bone replacement composition.
- the mineral component of bone replacement material preferably contains calcium.
- Others can include, for example, calcium carbonate, calcium sulfate, calcium sulfonate, polycalicum phosphate and mixtures thereof.
- Commercially available systems useful with the devices and methods of the present invention include Norian SRS® from Norian Corporation, PRO-OSTEONTM from Interpore Cross, FRIOS ALGIPORE® and VITOSS® from Orthovita, BIOSORB CERASORB® from Curasan, BIOBON® from Etex Corporation, and TRIOSITE® and COLLAGRAFTTM from Zimmer.
- the composite fulfills the general equation
- Calcium based mineral preparations are typically available in granular form with various sized granules with varying levels of porosity.
- a common commercially available preparation is a macroporous biphasic calcium phosphate (MBCP), which can consist of a combination of HA and beta-tricalcium phosphate.
- MBCP macroporous biphasic calcium phosphate
- a suitable MBCP product is available from Biomatlante (Fr.).
- a common MBCP material can contain a blend of approximately 60% HA and 40% beta-tricalcium phosphate. Such granules are typically described in terms of an apparent and skeletal density. This means, for example, that 1.0 g of MBCP granules from Biomatlante, occupies a volume of 1.8 mL (i.e., its skeletal density). This is explained by the open porosity of the material which has been measured to be approximately 80.5%. In other words, approximately 1.45 mL ofthe 1.8 mL volume of MBCP is occupied by air depending on the skeletal density ofthe material used.
- the porosity of MBCP makes it an ideal material for bone replacement applications because glues such a fibrin glue can enter the pores of the MBCP which facilitates strong bonding.
- MBCP can be produced with other shapes, sizes and porosity leading therefore to different skeletal porosities which can be predicted, necessitating different fibrin glue volume.
- mixing is based on the replacement of the volume of air contained in the pores of the MBCP material by an equal volume of fibrin glue when these components are mixed in a container. Therefore, when mixed in a container in which a defined initial MBCP volume can be determined, the final volume ofthe MBCP/glue mixture typically will be the same as the initial volume ofthe MBCP.
- the volume ofthe liquid can be different.
- MBCP can be combined with a glue by an alternative means.
- MBCP granules can initially be coated with thrombin.
- fibrinogen can be introduced to the thrombin-coated MBCP granules.
- the thrombin and fibrinogen will react to form a fibrin glue that surrounds the MBCP granules.
- One reason for using thrombin-coated MBCP is to achieve a comparatively slow reaction between the thrombin and fibrinogen.
- the catalyst is adsorbed on the solid surface which simplifies the device.
- the substrate Once the substrate is injected into the micro, macro, and inter granular spaces, it reacts with the adsorbed thrombin almost at the same time leading to the formation of a homogeneous and regular fibrin network formed by thick twisted fibers. In this sense, this is heterogeneous catalysis since the reagents combine and transform at the interface between the liquid and the surface ofthe catalyst, as opposed to homogenous catalysis in which the catalyst is dissolved in a liquid.
- Coating with thrombin can be achieved by washing MBCP granules with a thrombin solution.
- the thrombin solution will include thrombin (10 IU/mL) and CaCl 2 (2.5 mM up to 40 mM).
- the MBCP granules are preferably washed with a CaCl 2 (2.5 mM) solution.
- a CaCl 2 (2.5 mM) solution As soon as the MBCP is mixed with a solution of thrombin, thrombin adsorbs on the granules The unadsorbed thrombin can be removed by washing with a low ionic strength buffer and then freeze dried.
- Another method of coating MBCP with thrombin involves using the DUPLOJECTTM system from Baxter Bioscience.
- the device consists of two syringes which contain thrombin and fibrinogen solution, respectively.
- the DUPLOJECT is then connected to a syringe containing MBCP granules.
- the thrombin is then injected into the MBCP containing syringe and then the excess liquid is reaspirated by pulling the plunger ofthe thrombin syringe back.
- the fibrinogen is then injected into the syringe containing the thrombin adsorbed MBCP granules.
- Still yet another method of coating MBCP with thrombin is to have the thrombin layer lyophilized or frozen (-18°C to -80°) on the top or bottom ofthe MBCP granules in the same syringe. A diluent is then aspirated into the syringe, thus dissolving the thrombin which then adsorbs on the MBCP granules.
- FIG. 1 shows a medical device of the present invention that allows for mixing of chemically reactive substances, and ultimately the extrusion ofthe final composition resulting from the chemical reaction between or among those substances.
- the medical device features a first container 10 having a first opening 11, the first container being adapted to contain a chemically reactive substance.
- a second container 12 is also provided having a second opening 13, the second container being adapted to contain a chemically reactive substance.
- a third container 14 having a third opening 15.
- a connector 16 connects the first opening 11, second opening 13, and third opening 15 such that the chemically reactive substances can travel into the connector to begin the mixing process, and thereafter capable of traveling through the third opening 15 into the third container 14.
- the third container can be disconnected from the connector.
- the composition can be extruded from the third container after removing or cutting the luer end ofthe third container.
- the containers utilized with the device are preferably syringes, although non-syringe containers can be employed.
- Syringes are preferred because they are well suited for the controlled delivery of volumetric quantities and because extrusion of contents therefrom can be achieved easily, safely, and reliably by using hand pressure when depressing the syringe plungers.
- Preferred syringes for use with the present invention include those described in U.S. Patent Application No. 09/801,864 entitled “Polymeric Syringe Body and Stopper,” which is incorporated herein by reference and made a part hereof.
- the connector 16 is preferably a Y-shaped female-female luer connection piece that is known in the art for the purpose of connecting multiple syringes. Depending on the particular application, various types of connectors may be used. Moreover, it may be desirable to employ more than one connector.
- first and second containers are syringes, it is preferred that they constitute a parallel dual syringe assembly whereby the plungers of both syringes can easily be retracted and depressed either simultaneously or sequentially.
- simultaneous extrusion can provide for the transfer of precise quantities of the first and second chemically reactive substances into the connector for mixing.
- This type of dual syringe system is know in the art and is exemplified by the system provided by Baxter BioScience under the name of DUPLOJECTTM and by Hemaedics, Inc. and sold under the trade name DUOFLO.
- a Y-shaped connector be used to connect the three syringes.
- the third container can additionally contain a substance that can become integrated into the final composition. More specifically, after the substances from the first two containers are transferred through the connector into the third container, those substances wll mix with the contents ofthe third container to form a final composition.
- the device can be used to mix and extrude any substances that, when mixed, produce a medically useful composition. In addition, the device can also be used for non-medical applications such as the embedding of resin or mixing without sedimentation. However, when this invention is used for purposes of mixing and extruding bone replacement materials, it is preferred that the first two containers contain the fibrinogen and thrombin components, respectively, that are necessary to form a fibrin glue.
- the contents ofthe third container contain a mineral component such as biphasic calcium phosphate material (MBCP).
- MBCP biphasic calcium phosphate material
- other types of reactive glue components can be present in the first and second containers, and other types of mineral substrates can be used in the third container.
- FIG. 2 shows another medical device of the present invention that allows for mixing of chemically reactive substances, and ultimately the extrusion of the final composition resulting from the chemical reaction between or among those substances.
- the medical device features a first container 20 having a first opening 21, the first container being adapted to contain a chemically reactive substance.
- the device additionally features a second container 22 having a second opening 23, the second container being adapted to contain a chemically reactive substance.
- a connector 24 connects the first opening and second openings 21, 23 such that the substance from the first container 20 can travel through the connector 24 and through the second opening 23 into the second container 22 where it can react with the substance(s) contained in the second container 22.
- the composition can be extruded from the second container after removing or cutting the luer end.
- the containers utilized with the device are preferably syringes.
- Syringes are preferred because they are well suited for the controlled delivery of volumetric quantities and because extrusion of contents therefrom can be achieved easily, safely, and reliably by using hand pressure when depressing the syringe plungers.
- the connector 24 is preferably a female-female luer.
- various types of connectors may be used.
- FIG. 3 shows another medical device of the present invention that allows for mixing of chemically reactive substances, and ultimately the extrusion of the final composition resulting from the chemical reaction between or among those substances.
- the medical device features a syringe assembly with a hollow tube 30 that has a forward opening 31 and a rear opening 32 and a plunger 33.
- a removable cap 34 can be used to cover the forward opening.
- the removable cap 34 can be secured over the forward opening 31 preferably by mating threads.
- the removable cap 34 additionally contains a female luer port 35 into which a male luer tip 38 can be inserted.
- the port has a removable cover 36 attached by a retaining member 37.
- FIGS. 4a-c shows an alternative embodiment of the device of FIG. 3 having the cap
- the male luer tip 38 can be removed by lifting the male luer tip 38 from the female luer 35 and moving through an angle of approximately 30° and inserting into a docking port 39 (FIG. 4c) (defining a docking position) which is preferably shaped like a female luer.
- a docking port 39 (FIG. 4c) (defining a docking position) which is preferably shaped like a female luer.
- Another advantage of the design of the syringe body of the present invention is that the pitches are on the external side of the syringe body and not the inside. This results in there being no restriction of the diameter ofthe syringe body and that the composite can be extruded without scratching or destroying its shape. Therefore, the diameter ofthe composite equals the diameter ofthe syringe.
- All of the devices of the present invention can be used to mix and extrude any substances that, when mixed, produce a medically useful composition. However, all of the devices are especially suitable for the mixing and extrusion of bone replacement materials such as those comprising MBCP and fibrin glue.
- thrombin provides the catalyst that, when reacted with fibrinogen, causes fibrinogen to form fibrin monomers. It is therefore necessary that the thrombin and fibrinogen be segregated within the devices until the time at which their mixing is desired.
- the devices ofthe present invention allow for such segregation ofthe chemically reactive components.
- the three-container device shown in FIG. 1 can be used to mix and extrude any medically useful composition. However, when it is used to mix and extrude a bone replacement composition such as that resulting from MBCP and fibrin glue, a preferred method of use for the device is as follows.
- fibrinogen can be placed in the first container 10.
- Thrombin can be placed in the second container 12.
- MBCP granules can be placed in the third container 14.
- the first, second, and third containers can be attached via the connector 16.
- the fibrinogen and the thrombin in the first and second containers 10, 12 can be forced into the connector 16 where they begin the mixing process.
- These substances are further forced into the third container 14 where they can surround the MBCP granules.
- the fibrin glue will penetrate the pores of the MBCP granules, as well as the inter-granular space.
- the connector can optionally be disconnected from the third container.
- the final bone replacement material can then be extruded from the third container for its intended medical purpose.
- the opening for extrusion can vary depending on the wishes of the practitioner.
- Standard syringe barrels have a tapered distal end 15. In this regard, it may be desirable to separate the reduced diameter portion or the syringe barrel from a constant diameter portion of the third container 14.
- the method of separating the reduced diameter portion from the constant diameter portion can include unscrewing one port from the other or breaking one port away from the other along a frangible portion.
- the screw type system is more desirable than the frangible type as the frangible system can form undesired particulates.
- Another way to extrude the composite out ofthe syringe without cutting the luer end may be performed by removing the plunger and pushing the composite out mechanically or with air.
- the two-container device shown in FIG. 2 can be used to mix and extrude any medically useful composition. However, when it is used to mix and extrude a bone replacement composition such as that resulting from MBCP and fibrin glue, a preferred method of use for the device is as follows.
- fibrinogen can be placed in the first container 20.
- MBCP component MBCP granules pre-adsorbed with thrombin, a mixture of MBCP granules adsorbed with thrombin and MBCP granules adsorbed or coated with molecules such as bone morphogenetic proteins (BMP's), or a mix of at least two specfes of MBCP granules pre-adsorbed with different molecules can be used. These mixtures may be homogeneous or in layers.
- BMP's bone morphogenetic proteins
- the fibrinogen in the first container 20 is forced through the connector 24 into the second container 22 where it can react with the thrombin on the pre-coated thrombin MBCP granules.
- the reaction between the thrombin and the fibrinogen serves to create the fibrin glue that will bind in and around the MBCP granules.
- the connector24 optionally can be disconnected from the second container 22.
- the final bone replacement material can then be extruded from the second container 22 for its intended medical purpose.
- the opening for extrusion can vary depending on the wishes of the practitioner. Standard syringe barrels have a tapered distal end21, 23.
- the method of separating the reduced diameter portion from the constant diameter portion can include unscrewing one port from the other or breaking one port away from the other along a frangible portion.
- the screw type system is more desirable than the frangible type as the frangible system can form undesired particulates.
- the devices shown in FIGS. 1 and 2 can additionally be used in a manner whereby the contents are placed in the respective containers to be stored at room temperature or quickly frozen or freeze dried for later use. For this kind of application, it may be desirable to store the loaded/frozen device in a blister pack for later use.
- 1 and 2 are preferably syringes.
- syringes When typical syringes are used, it is assumed that the contents for the various containers can be transferred among the containers and/or connector via the action of the syringe plunger that is driven manually by hand-force. However, even when syringes are used, it may be desirable to use automated techniques to depress the syringe plungers. Moreover, if non-syringe containers are employed, then the practitioner may use other methods to transfer the container contents between and among the containers and/or connector. Such schemes for transferring contents will depend on the type of container/connector employed, and may include, for example, gravity.
- the one-container device shown in FIG. 3 can be used to mix and extrude any medically useful composition. However, when it is used to mix and extrude a bone replacement composition such as that resulting from MBCP and fibrin glue, a preferred method of use for the device is as follows.
- the plunger is retracted.
- the screw cap 34 is removed to expose the barrel 30 of the device.
- the device is then tilted such that the uncapped barrel end is pointed upward.
- the device is filled with a specific quantity of fibrinogen and then frozen (with the uncapped barrel remaining facing upward) at a temperature of approximately 0°C or below, preferably -18°C, and most preferably at -80°C.
- fibrinogen is frozen, thrombin-coated MBCP granules are placed in the device barrel immediately atop the frozen fibrinogen.
- the screw cap is quickly attached and the entire device is again stored at approximately 0°C or colder, preferably -18°C.
- the device When ready for use, the device (and contents loaded therein) can be removed from the freezer and allowed to thaw at room temperature. After thawing, the plunger is pushed to force the fibrinogen solution to fill out the micro, macro, and inter granular spaces of the thrombin adsorbed HA granules. The screw cap is removed and the composition can be extruded. In this sense the device is an "All in One" device since the fibrinogen, thrombin and MBCP granules are all packed within the same syringe.
- the fibrinogen and thrombin adsorbed MBCP granules within the device.
- granules coated or adsorbed with other molecules such as BMP's can be used instead of regular MBCP granules, as well as mixtures of different coated granules.
- the first layer may be freeze dried thrombin and the second layer may be gelatin.
- the first layer may be BMP's frozen or freeze dried with the second layer being thrombin adsorbed MBCP granules.
- layer 1 will te thrombin frozen or freeze dried and layer 2 will be gelatin beads, fibers or powders, or collagen, alginate and any biopolymers synthetic or natural.
- Still yet another example includes a first layer being fibrinogen frozen or freeze dried and a second layer which will be a mix of thrombin adsorbed MBCP granules and BMP adsorbed MBCP granules. Frozen water can be used as a separator to avoid diffusion of molecules between the layers of the reactive agents.
- the second layer being homogeneously distributed or organized in separate but consecutive ' layers.
- the surgeon will reconstitute by aspirating with a liquid which can be water, buffer, polymerizing polymer synthetic or natural, and double component polymerizing material such as fibrin, plasma, and bone marrow with selected or all stem cells.
- a liquid which can be water, buffer, polymerizing polymer synthetic or natural, and double component polymerizing material such as fibrin, plasma, and bone marrow with selected or all stem cells.
- layer 1 will be fibrinogen frozen or freeze dried
- layer 2 will be thrombin frozen or freeze dried
- layer 3 will be MBCP granules or granules adsorbed with other molecules such as BMP, or a mixture thereof.
- layer 4 can be any liquid frozen or freeze dried. As with all of the other examples discussed in detail above, these layers may be placed in any sequence without affecting the overall operation ofthe device.
- the removable cap 34 of this device additionally contains a female luer port 35 into which a male luer tip can be inserted.
- the port has a removable cover 36.
- the purpose of the luer port is to facilitate the convenient injection and extraction of substances in and out of the device when the screw cap is in place.
- the cap 34 can optionally have a retaining member 37 to hold the removable cover 36 when the cover 36 is not inserted in the port 35.
- One advantage of he device shown in FIG. 3 is that it allows for sedimentation-free delivery of bone replacement materials. Thus, the liquid is injected into the granule layer and not the opposite.
- the liquid may be water, buffer, polymerizing material such as fibrin, plasma, bone marrow with selected or all stem cells, rich platelet plasma, autologous fibrinogen, recombinant proteins or any combination thereof.
- the liquid or liquids fill out voids in the form of micro, macro, or inter granular spaces of MBCP granules without disturbing or inducing motion of the MBCP granules, only displacing the equivalent volume of air, therefore the MBCP granules do not move. Moreover, it additionally allows for air- free delivery, which contrasts with the devices shown in FIGS. 1 and 2, both of which may trap air in the container prior to polymerization.
- the above devices are advantageous because they allow for mixing and extrusion to occur in a single device. Moreover, they are especially advantageous when used for mixing and delivery of bone replacement materials.
- these devices are used to mix fibrin glue with MBCP granules
- various aspects of the mixing process are optimized. Fibrin polymerizes in the inter- and intra- granular spaces ofthe MBCP granules, insuring a homogeneous distribution of fibrin in the mixture. This leads to a beneficial 3D structure of fibrin that is protected from shear stress providing a network for cell ingrowth.
- there is no excess of fibrin glue and no risk of void volume formation once fibrin is degraded is avoided.
- mechanical properties such as break at compression and Young modulus should be unchanged, while elasticity ofthe mixture should be improved.
- Another advantage of the devices of the present invention is the optimization of the injectibility factor ofthe composite.
- Calcium phosphate cement have been in clinical use for at least 10 years.
- CPC calcium phosphate cement
- a pressure, ⁇ pn is applied on the paste. If the applied pressure is high enough to press the mixing liquid through the cement particles, filter pressing will occur.
- the ability of a cement to sustain filter pressing can be defined as the ratio between the pressure required to press the liquid through the particles divided by the pressure required to push the cement through the needle ( ⁇ pn).
- ⁇ pn the ratio between the pressure required to press the liquid through the particles divided by the pressure required to push the cement through the needle
- the injectability based on the two definitions above, is independent from: size of the granules used, shape and porosity of the granules (compaction effect), temperature of use, kinetic of the polymerization of fibrin, time after mixing, force required to inject the composite (extrusion force), and needle (needleless).
- a good cement or composite injectability can only be reached when filter pressing does not occur i.e. when ⁇ p is very low, which means when ⁇ is large.
- Other authors define the injectability based on the calculation ofthe weight percentage ofthe extruded paste to the total mass of cement paste. AAlmirall, Proceedings of the 17 th European Conference on Biomaterials reference:T70.
- the present invention maximizes injectibility since 100% of the composite weight is extruded.
- the device of the present invention does not suffer from the filter pressing effect. Indeed, when there is filter pressing, liquid will percolate through the solid particle and exit the syringe or device, which means that the homogeneity ofthe composite extruded will be different. This will result in the first portion of the composite extruded having more liquid than the composite at the end.
- the opening Based on one design ofthe syringe body in accordance with the present invention, the opening has the same diameter as the internal diameter ofthe body of the syringe. Therefore, no filter pressing is observed and a good injectability is achieved because ofthe design features ofthe devices of the present invention. These features include the exit equaling the internal diameter of the syringe, a luer end that can be unscrewed, and the lubricating effect of the water and fibrin glue distributed in the granules bed.
- thrombin is adsorbed on polymers such as PVC or polyolefin, polyethylene, and polypropylene such as the materials used for fabricating commercially available syringes. Therefore, it is possible to adsorb thrombin on the inner wall of a syringe which will then be loaded with MBCP granules.
- the device containg the MBCP granules may then be connected to a syringe containing fibrinogen, which is injected into the MBCP granule layer.
- the volumetric requirements of mixing the mineral component with the glue components are very predictable when employing the devices of the present invention for mixing.
- the liquid when mixed in a syringe the liquid will enter the pores of the mineral component as well as surround the extra-granular spaces around the granules.
- the bone replacement material can include from about 10% to about 100% mineral and from about 30% to about 100% glue (e.g., fibrin glue).
- glue e.g., fibrin glue
- the devices and methods of the present invention can be utilized for numerous applications, including those associated with osteopathic uses.
- a professional can use equipment known in the art to initially scan the target bone to determine the extentof a given defect and, if necessary, the volume of the defect that potentially requires treatment with a bone replacement composition.
- the surgeon can use software in order to chose the MBCP based on the application, since different types of MBCP have different skeletal porosity, density and shape. Normally, a surgeon will want to pack as much of the bone defect with an optimal mass MBCP.
- Vd the bone defect volume
- the surgeon using the software can make the choice for a particular MBCP material having its specifications and determine the volume of fibrin required to fully immerse the MBCP.
- the exact mixture of components ofthe mixture will vary depending on the type of bone and the nature of the bone defect.
- the mixture can be predicted and manipulated to include mineral granules of varying porosities and glues that have varying bonding strengths and polymerization rates.
- the material can be applied to the target bone and molded accordingly.
- Another feature of the present invention is described as follows, after mixing the composite is freeze dried in the syringe, capped, and packaged in a rigid blister.
- a different diameter of syringe will provide the surgeon with a different diameter of extruded material.
- the practitioner can then use a surgical drill to drill holes in the target bone and plug the holes using appropriate "off the shelf bone replacement material as cylinders, carrots or plugs, edges, and squares.
- These "off the shelf materials could be presented in a device having the shape ofthe material and equipped with a luer to be connected with a syringe that contains another liquid or liquids to be injected.
- the plugs can be textured on their outer surfaces to reduce surface contact for ease of insertion. However, it is desired to have as much surface contact as reasonably possible with the bone wall defect.
- FIG. 5 a scanning electron micrograph of a cross-section of a sample of bone replacement material mixed and extruded using a device of the present invention is shown.
- the bone replacement material consists of MBCP/fibrin glue.
- a fibrin membrane is formed around the MBCP/fibrin mixture.
- FIG. 6 is a scanning electron micrograph of a cross-section of another sample of bone replacement material mixed and extruded using a device ofthe present invention.
- Dark gray areas show the fibrin polymer which is present in all inter-granular spaces as well as inside the pores of the granules.
- the light gray areas represent surface areas ofthe MBCP granules.
- Example 1 Mixing and Extrusion in a Three-Container Device.
- 1.45 mL fibrinogen (100 mg/mL) was placed in a first syringe barrel as depicted in FIG. 1.
- 1.45 mL thrombin (4IU/mL) was placed in a second syringe barrel as depicted in FIG 1.
- the first and second syringe barrels were part of a dual syringe assembly sold under the trade name of DUOFLO (Hemaedics).
- DUOFLO Hemaedics
- the DUPLOJECT system available from Baxter Bioscience may also be used.
- 2.0 g MBCP was placed in a third syringe barrel as depicted in FIG. 1. The three syringes were connected using a Yshaped female-female luer connection piece.
- the medical device was tilted such that the MBCP- containing syringe barrel pointed downward toward the syringe barrels containing fibrinogen and thrombin. Using hand pressure, the fibrinogen and thrombin were forced upward through the connector and into the MBCP-containing syringe. After polymerization, the syringe containing the MBCP-fibrin glue composition was disconnected from the connector and was cut at its distal end. The MBCP-fibrin glue mixture was then extruded by applying hand pressure to the syringe plunger.
- Example 2 Mixing and Extrusion in a 2-Container Device
- MBCP granules were pre-coated with thrombin. Coating with thrombin was achieved using the following procedure. 1.0 g of MBCP granules was placed in a 3.0 mL syringe. The MBCP-containing syringe was connected to a syringe containing 2.0 mL thrombin solution
- thrombin solution (10 IU/mL in CaCl 2 2.5 mM (concentration of CaCl 2 can be increased to up to 40mM); syringe not shown in FIG. 2).
- 1.5 mL thrombin solution was injected into the MBCP- containing syringe.
- the thrombin solution was re-aspirated back from the MBCP-containing syringe, 0.9 to 1.0 mL remains into the MBCP.
- the MBCP granules may optionally be washed with a CaCl 2 2.5 mM solution, depending on the clotting time or polymerization time required.
- 1.5 mL of fibrinogen at 50 mg/mL was placed into a second syringe as depicted in FIG.
- the medical device was tilted such that the thrombin adsorbed MBCP-containing syringe barrel pointed downward toward the syringe barrel containing fibrinogen.
- the fibrinogen was forced upward through the connector and into the thrombin adsorbed MBCP- containing syringe.
- the syringe containing the MBCP-fibrin glue composition was disconnected from the connector and was cut at its distal end. The MBCP- fibrin glue mixture was then extruded by applying hand pressure to the syringe plunger.
- Example 3 Mixing and Extrusion in a 1-Container Device
- the plunger ofthe single-container device as shown in FIG. 3 was retracted.
- the screw cap was removed to expose the barrel of the device.
- the device was then tilted such that the uncapped barrel end pointed upward.
- the device was filled with 1.5 mL fibrinogen (50 mg/mL) and frozen (with the uncapped barrel remaining facing upward) at a temperature of approximately -18° C or below.
- 1.0 g ofthe thrombin-adsorbed MBCP granules of Example 2 were placed in the device barrel immediately atop the frozen fibrinogen.
- the screw cap was quickly attached and the entire device was stored at approximately -18° C or below.
- the device When ready for use, the device was removed from the freezer and allowed to thaw at room temperature or at 37° C. After thawing, the melted fibrinogen solution was pushed with the plunger to fill out the skeletal porosity of the granules to mix with the thrombin-adsorbed MBCP. It should be noted that 1.5 mL of a solution, in this case, fibrinogen can fill out the porosity of 1.0 g of MBCP. The screw cap was then removed and the composition was extruded.
- Hydration with water was achieved using the following procedure. 1.0 g of MBCP granules were placed in a 3.0 mL syringe. The MBCP-containing syringe was connected to a syringe containing 2.0 mL of water. Water was injected into the MBCP-containing syringe. The excess of water was re-aspirated back from the MBCP-containing syringe, 0.9 to 1.0 mL remains into the MBCP. The syringe containing the excess of water is discarded. 0.5 mL fibrinogen (100 mg/mL) was placed in a first syringe barrel as depicted in FIG. 1.
- thrombin 4IU/mL was placed in a second syringe barrel as depicted in FIG 1.
- the first and second syringe barrels were part of a dual syringe assembly sold under the trade name of DUOFLO (Hemaedics).
- DUOFLO Hemaedics
- the DUPLOJECT system available from Baxter Bioscience may also be used.
- Hydrated MBCP (1.0 g) is placed in a third syringe barrel as depicted in FIG. 1. The three syringes were connected using a Yshaped and the female-female luer connection piece.
- the medical device was tilted such that the MBCP- containing syringe barrel pointed downward toward the syringe barrels containing fibrinogen and thrombin. Using hand pressure, the fibrinogen and thrombin were forced upward through the connector and into the MBCP-containing syringe. After polymerization, the syringe containing the MBCP-fibrin glue composition was disconnected from the connector and was cut at its distal end. The MBCP-fibrin glue mixture was then extruded by applying hand pressure to the syringe plunger.
- Example 5 Mixing and Extrusion Using a Water Gap
- the first reagent fibrinogen (lOOmg/mL) was poured into the single-container device as shown in FIG. 3 and frozen at a temperature of approximately - 18°C.
- a non-reactive substance which in this example was pure water was then poured over the frozen fibrinogen layer and the syringe was frozen again at a temperature of approximately -18°C.
- the amount of water used was enough to create an interface of at least 1 mm between the first and second reactant.
- the device was then filled with 1.0 ml at 4 IU/mL of a second reagent thrombin which was poured over the non-reactive layer of frozen water.
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20030759741 EP1545403B1 (en) | 2002-10-04 | 2003-10-03 | Devices and methods for mixing and extruding medically useful compositions |
DE60329307T DE60329307D1 (en) | 2002-10-04 | 2003-10-03 | APPARATUS AND METHOD FOR MIXING AND EXTRUDING MEDIUM USEFUL COMPOSITIONS |
AU2003275463A AU2003275463A1 (en) | 2002-10-04 | 2003-10-03 | Devices and methods for mixing and extruding medically useful compositions |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/265,076 | 2002-10-04 | ||
US10/265,076 US7135027B2 (en) | 2002-10-04 | 2002-10-04 | Devices and methods for mixing and extruding medically useful compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004032808A2 true WO2004032808A2 (en) | 2004-04-22 |
WO2004032808A3 WO2004032808A3 (en) | 2004-08-19 |
Family
ID=32042396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/031691 WO2004032808A2 (en) | 2002-10-04 | 2003-10-03 | Devices and methods for mixing and extruding medically useful compositions |
Country Status (5)
Country | Link |
---|---|
US (2) | US7135027B2 (en) |
EP (1) | EP1545403B1 (en) |
AU (1) | AU2003275463A1 (en) |
DE (1) | DE60329307D1 (en) |
WO (1) | WO2004032808A2 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006128564A1 (en) * | 2005-05-31 | 2006-12-07 | Baxter International Inc. | Polypropylene hollow barrel with sliding coated rubber piston |
US7713303B2 (en) | 2002-09-18 | 2010-05-11 | Warsaw Orthopedic, Inc. | Collagen-based materials and methods for augmenting intervertebral discs |
US7731981B2 (en) | 2002-11-15 | 2010-06-08 | Warsaw Orthopedic, Inc. | Collagen-based materials and methods for treating synovial joints |
US7744651B2 (en) | 2002-09-18 | 2010-06-29 | Warsaw Orthopedic, Inc | Compositions and methods for treating intervertebral discs with collagen-based materials |
US8118779B2 (en) | 2006-06-30 | 2012-02-21 | Warsaw Orthopedic, Inc. | Collagen delivery device |
US8399619B2 (en) | 2006-06-30 | 2013-03-19 | Warsaw Orthopedic, Inc. | Injectable collagen material |
DE202013010100U1 (en) * | 2013-11-07 | 2015-02-09 | Mathys Ag Bettlach | Dosing device for filling Appliziervorrichtungen with bone cement or bone replacement pastes |
TWI705811B (en) * | 2015-06-19 | 2020-10-01 | 美商巴克斯歐塔公司 | Pooling device for single or multiple medical containers |
US11903900B2 (en) | 2018-10-03 | 2024-02-20 | Takeda Pharmaceutical Company Limited | Packaging for multiple containers |
Families Citing this family (544)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11337894B2 (en) | 2018-06-15 | 2022-05-24 | James T. Doubet | Syringe adapter for animal medication |
US11090444B2 (en) | 2018-06-15 | 2021-08-17 | James T. Doubet | Syringe adapter for medication |
US10709850B2 (en) | 2018-06-15 | 2020-07-14 | James T. Doubet | Syringe adapter for medication |
US11097058B2 (en) | 2018-06-15 | 2021-08-24 | James T. Doubet | Syringe adapter for medication |
DE10032220A1 (en) * | 2000-07-03 | 2002-01-24 | Sanatis Gmbh | Magnesium ammonium phosphate cements, their manufacture and use |
WO2003054146A2 (en) * | 2001-11-14 | 2003-07-03 | Northwestern University | Self-assembly and mineralization of peptide-amphiphile nanofibers |
SE522098C2 (en) * | 2001-12-20 | 2004-01-13 | Bone Support Ab | Artificial bone mineral substitute material useful as an X-ray contrast medium comprises ceramic and water soluble non-ionic X-ray contrast agent |
WO2003070749A2 (en) * | 2002-02-15 | 2003-08-28 | Northwestern University | Self-assembly of peptide-amphiphile nanofibers under physiological conditions |
US20030175410A1 (en) * | 2002-03-18 | 2003-09-18 | Campbell Phil G. | Method and apparatus for preparing biomimetic scaffold |
US8529956B2 (en) | 2002-03-18 | 2013-09-10 | Carnell Therapeutics Corporation | Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom |
US8293530B2 (en) * | 2006-10-17 | 2012-10-23 | Carnegie Mellon University | Method and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom |
SE519974C2 (en) * | 2002-06-03 | 2003-05-06 | Cemvac System Ab | Device for dispensing a monomer to a polymer-filled mixing device for preparing bone cement |
US7273523B2 (en) * | 2002-06-07 | 2007-09-25 | Kyphon Inc. | Strontium-apatite-cement-preparations, cements formed therefrom, and uses thereof |
US8227411B2 (en) * | 2002-08-20 | 2012-07-24 | BioSurface Engineering Technologies, Incle | FGF growth factor analogs |
US7598224B2 (en) * | 2002-08-20 | 2009-10-06 | Biosurface Engineering Technologies, Inc. | Dual chain synthetic heparin-binding growth factor analogs |
US7554021B2 (en) * | 2002-11-12 | 2009-06-30 | Northwestern University | Composition and method for self-assembly and mineralization of peptide amphiphiles |
US9060770B2 (en) | 2003-05-20 | 2015-06-23 | Ethicon Endo-Surgery, Inc. | Robotically-driven surgical instrument with E-beam driver |
US20070084897A1 (en) | 2003-05-20 | 2007-04-19 | Shelton Frederick E Iv | Articulating surgical stapling instrument incorporating a two-piece e-beam firing mechanism |
EP1656214B1 (en) * | 2003-08-21 | 2010-02-24 | Medmix Systems AG | Device and method for transferring, mixing and delivering components |
SE0302983D0 (en) * | 2003-11-11 | 2003-11-11 | Bone Support Ab | Apparatus for providing spongy bone with bone replacement and / or bone strengthening material and associated method |
CN102225964A (en) * | 2003-12-05 | 2011-10-26 | 西北大学 | Self-assembling peptide amphiphiles and related methods for growth factor delivery |
US20080227696A1 (en) * | 2005-02-22 | 2008-09-18 | Biosurface Engineering Technologies, Inc. | Single branch heparin-binding growth factor analogs |
WO2005082005A2 (en) | 2004-02-20 | 2005-09-09 | Biosurface Engineering Technologies, Inc., Et Al. | Positive modulator of bone morphogenic protein-2 |
US20050186240A1 (en) * | 2004-02-23 | 2005-08-25 | Ringeisen Timothy A. | Gel suitable for implantation and delivery system |
ES2396133T3 (en) * | 2004-04-27 | 2013-02-19 | Kyphon SÀRl | Bone replacement compositions and method of use |
US20050282117A1 (en) * | 2004-05-05 | 2005-12-22 | Aravena Ines M | Systems and methods for dispensing sealant in medical applications |
SE527528C2 (en) * | 2004-06-22 | 2006-04-04 | Bone Support Ab | Apparatus for the preparation of curable pulp and use of the apparatus |
US11890012B2 (en) | 2004-07-28 | 2024-02-06 | Cilag Gmbh International | Staple cartridge comprising cartridge body and attached support |
US8215531B2 (en) | 2004-07-28 | 2012-07-10 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument having a medical substance dispenser |
US20060078591A1 (en) * | 2004-10-08 | 2006-04-13 | Del Vecchio Daniel A | Systems and methods for augmenting tissue volume |
CN101180094B (en) * | 2004-12-23 | 2011-03-23 | 丰收技术股份有限公司 | Hydrating anhydrous graft materials |
MX2007008826A (en) * | 2005-01-21 | 2007-11-15 | Univ Northwestern | Methods and compositions for encapsulation of cells. |
KR20070108555A (en) * | 2005-03-04 | 2007-11-12 | 노오쓰웨스턴 유니버시티 | Angiogenic heparin binding peptide amphiphiles |
CN101166487A (en) * | 2005-04-29 | 2008-04-23 | 惠氏公司 | Drug delivery devices and related components, systems and methods |
US7575131B2 (en) * | 2005-07-13 | 2009-08-18 | Ethicon, Inc. | Multi-component delivery system |
US7651701B2 (en) | 2005-08-29 | 2010-01-26 | Sanatis Gmbh | Bone cement composition and method of making the same |
US10159482B2 (en) | 2005-08-31 | 2018-12-25 | Ethicon Llc | Fastener cartridge assembly comprising a fixed anvil and different staple heights |
US9237891B2 (en) | 2005-08-31 | 2016-01-19 | Ethicon Endo-Surgery, Inc. | Robotically-controlled surgical stapling devices that produce formed staples having different lengths |
US11246590B2 (en) | 2005-08-31 | 2022-02-15 | Cilag Gmbh International | Staple cartridge including staple drivers having different unfired heights |
US7669746B2 (en) | 2005-08-31 | 2010-03-02 | Ethicon Endo-Surgery, Inc. | Staple cartridges for forming staples having differing formed staple heights |
US7934630B2 (en) | 2005-08-31 | 2011-05-03 | Ethicon Endo-Surgery, Inc. | Staple cartridges for forming staples having differing formed staple heights |
US11484312B2 (en) | 2005-08-31 | 2022-11-01 | Cilag Gmbh International | Staple cartridge comprising a staple driver arrangement |
US7673783B2 (en) * | 2005-11-04 | 2010-03-09 | Ethicon Endo-Surgery, Inc. | Surgical stapling instruments structured for delivery of medical agents |
US20070106317A1 (en) | 2005-11-09 | 2007-05-10 | Shelton Frederick E Iv | Hydraulically and electrically actuated articulation joints for surgical instruments |
PL1973475T3 (en) * | 2006-01-17 | 2011-05-31 | Baxter Int | Device, system and method for mixing |
US20090038701A1 (en) | 2006-01-17 | 2009-02-12 | Baxter International Inc. | Device, system and method for mixing |
US20110024477A1 (en) | 2009-02-06 | 2011-02-03 | Hall Steven G | Driven Surgical Stapler Improvements |
US7753904B2 (en) | 2006-01-31 | 2010-07-13 | Ethicon Endo-Surgery, Inc. | Endoscopic surgical instrument with a handle that can articulate with respect to the shaft |
US20120292367A1 (en) | 2006-01-31 | 2012-11-22 | Ethicon Endo-Surgery, Inc. | Robotically-controlled end effector |
US11224427B2 (en) | 2006-01-31 | 2022-01-18 | Cilag Gmbh International | Surgical stapling system including a console and retraction assembly |
US11278279B2 (en) | 2006-01-31 | 2022-03-22 | Cilag Gmbh International | Surgical instrument assembly |
US7845537B2 (en) | 2006-01-31 | 2010-12-07 | Ethicon Endo-Surgery, Inc. | Surgical instrument having recording capabilities |
US8820603B2 (en) | 2006-01-31 | 2014-09-02 | Ethicon Endo-Surgery, Inc. | Accessing data stored in a memory of a surgical instrument |
US8708213B2 (en) | 2006-01-31 | 2014-04-29 | Ethicon Endo-Surgery, Inc. | Surgical instrument having a feedback system |
US11793518B2 (en) | 2006-01-31 | 2023-10-24 | Cilag Gmbh International | Powered surgical instruments with firing system lockout arrangements |
US20110290856A1 (en) | 2006-01-31 | 2011-12-01 | Ethicon Endo-Surgery, Inc. | Robotically-controlled surgical instrument with force-feedback capabilities |
US8186555B2 (en) | 2006-01-31 | 2012-05-29 | Ethicon Endo-Surgery, Inc. | Motor-driven surgical cutting and fastening instrument with mechanical closure system |
US8992422B2 (en) | 2006-03-23 | 2015-03-31 | Ethicon Endo-Surgery, Inc. | Robotically-controlled endoscopic accessory channel |
US7754005B2 (en) * | 2006-05-02 | 2010-07-13 | Kyphon Sarl | Bone cement compositions comprising an indicator agent and related methods thereof |
CA2651820C (en) * | 2006-05-26 | 2015-01-13 | Baxter International Inc. | Injectable bone void filler |
EP2029184B1 (en) * | 2006-05-26 | 2011-02-23 | Baxter International Inc. | Injectable fibrin composition for bone augmentation |
US7820172B1 (en) | 2006-06-01 | 2010-10-26 | Biosurface Engineering Technologies, Inc. | Laminin-derived multi-domain peptides |
US7507286B2 (en) * | 2006-06-08 | 2009-03-24 | Sanatis Gmbh | Self-foaming cement for void filling and/or delivery systems |
EP2046350A4 (en) | 2006-06-22 | 2011-09-14 | Biosurface Eng Tech Inc | Composition and method for delivery of bmp-2 amplifier/co-activator for enhancement of osteogenesis |
US8322455B2 (en) | 2006-06-27 | 2012-12-04 | Ethicon Endo-Surgery, Inc. | Manually driven surgical cutting and fastening instrument |
US20080154229A1 (en) * | 2006-07-26 | 2008-06-26 | Lambert Systems, L.L.C. | Device And Method For Mixing And Delivering Bone Cement Precursors |
WO2008030668A2 (en) * | 2006-07-26 | 2008-03-13 | Lambert Systems, L.L.C. | Biocompatible anchoring device for a soft tissue graft, method of making and method of using |
WO2008030742A2 (en) * | 2006-09-07 | 2008-03-13 | Wyeth | Bone cement mixing systems and related methods |
US10568652B2 (en) | 2006-09-29 | 2020-02-25 | Ethicon Llc | Surgical staples having attached drivers of different heights and stapling instruments for deploying the same |
US20080078802A1 (en) | 2006-09-29 | 2008-04-03 | Hess Christopher J | Surgical staples and stapling instruments |
US8529961B2 (en) | 2006-10-17 | 2013-09-10 | Carmell Therapeutics Corporation | Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom |
US8388626B2 (en) * | 2006-11-08 | 2013-03-05 | Warsaw Orthopedic, Inc. | Methods of employing calcium phosphate cement compositions and osteoinductive proteins to effect vertebrae interbody fusion absent an interbody device |
US8652120B2 (en) | 2007-01-10 | 2014-02-18 | Ethicon Endo-Surgery, Inc. | Surgical instrument with wireless communication between control unit and sensor transponders |
US11291441B2 (en) | 2007-01-10 | 2022-04-05 | Cilag Gmbh International | Surgical instrument with wireless communication between control unit and remote sensor |
US8684253B2 (en) | 2007-01-10 | 2014-04-01 | Ethicon Endo-Surgery, Inc. | Surgical instrument with wireless communication between a control unit of a robotic system and remote sensor |
US20080169332A1 (en) | 2007-01-11 | 2008-07-17 | Shelton Frederick E | Surgical stapling device with a curved cutting member |
US11039836B2 (en) | 2007-01-11 | 2021-06-22 | Cilag Gmbh International | Staple cartridge for use with a surgical stapling instrument |
US20090001121A1 (en) | 2007-03-15 | 2009-01-01 | Hess Christopher J | Surgical staple having an expandable portion |
AU2008230916B2 (en) * | 2007-03-26 | 2013-10-03 | Baxter Healthcare S.A. | Injectable void filler for soft tissue augmentation |
US8893946B2 (en) | 2007-03-28 | 2014-11-25 | Ethicon Endo-Surgery, Inc. | Laparoscopic tissue thickness and clamp load measuring devices |
US8076295B2 (en) * | 2007-04-17 | 2011-12-13 | Nanotope, Inc. | Peptide amphiphiles having improved solubility and methods of using same |
US11672531B2 (en) | 2007-06-04 | 2023-06-13 | Cilag Gmbh International | Rotary drive systems for surgical instruments |
US8931682B2 (en) | 2007-06-04 | 2015-01-13 | Ethicon Endo-Surgery, Inc. | Robotically-controlled shaft based rotary drive systems for surgical instruments |
US7753245B2 (en) | 2007-06-22 | 2010-07-13 | Ethicon Endo-Surgery, Inc. | Surgical stapling instruments |
US11849941B2 (en) | 2007-06-29 | 2023-12-26 | Cilag Gmbh International | Staple cartridge having staple cavities extending at a transverse angle relative to a longitudinal cartridge axis |
US8083748B2 (en) * | 2007-12-27 | 2011-12-27 | Cook Biotech Incorporated | Device and method for mixing and dispensing a bone cement mixture |
US8974465B2 (en) | 2007-12-27 | 2015-03-10 | Cook Medical Technologies Llc | Device and method for mixing and dispensing a bone cement mixture |
US8758391B2 (en) | 2008-02-14 | 2014-06-24 | Ethicon Endo-Surgery, Inc. | Interchangeable tools for surgical instruments |
BRPI0901282A2 (en) | 2008-02-14 | 2009-11-17 | Ethicon Endo Surgery Inc | surgical cutting and fixation instrument with rf electrodes |
US8636736B2 (en) | 2008-02-14 | 2014-01-28 | Ethicon Endo-Surgery, Inc. | Motorized surgical cutting and fastening instrument |
US8573465B2 (en) | 2008-02-14 | 2013-11-05 | Ethicon Endo-Surgery, Inc. | Robotically-controlled surgical end effector system with rotary actuated closure systems |
US7819298B2 (en) | 2008-02-14 | 2010-10-26 | Ethicon Endo-Surgery, Inc. | Surgical stapling apparatus with control features operable with one hand |
US7866527B2 (en) | 2008-02-14 | 2011-01-11 | Ethicon Endo-Surgery, Inc. | Surgical stapling apparatus with interlockable firing system |
US9179912B2 (en) | 2008-02-14 | 2015-11-10 | Ethicon Endo-Surgery, Inc. | Robotically-controlled motorized surgical cutting and fastening instrument |
US11272927B2 (en) | 2008-02-15 | 2022-03-15 | Cilag Gmbh International | Layer arrangements for surgical staple cartridges |
US10390823B2 (en) | 2008-02-15 | 2019-08-27 | Ethicon Llc | End effector comprising an adjunct |
US8512740B2 (en) * | 2008-03-26 | 2013-08-20 | Baxter International Inc. | Fibrin foam and process for making |
US8753670B2 (en) | 2008-03-26 | 2014-06-17 | Baxter International Inc. | Fibrin foam and process |
US7968616B2 (en) * | 2008-04-22 | 2011-06-28 | Kyphon Sarl | Bone cement composition and method |
US20090281549A1 (en) * | 2008-05-12 | 2009-11-12 | Cook Incorporated | Bone cement mixing and delivery device and method of use |
US8052645B2 (en) | 2008-07-23 | 2011-11-08 | Avant Medical Corp. | System and method for an injection using a syringe needle |
US8177749B2 (en) | 2008-05-20 | 2012-05-15 | Avant Medical Corp. | Cassette for a hidden injection needle |
CA2724641C (en) | 2008-05-20 | 2020-03-24 | Avant Medical Corp. | Autoinjector system |
FR2932686B1 (en) * | 2008-06-23 | 2010-08-27 | Centre Nat Rech Scient | COMBINATION OF BLOOD AND CERAMIC PARTICLES OF CALCIUM BIPHASE PHOSPHATES. |
WO2010021749A2 (en) * | 2008-08-22 | 2010-02-25 | Circle Biologics, Llc | Fluid management devices and methods |
EP2430982B1 (en) | 2008-08-26 | 2020-06-24 | St. Jude Medical, Inc. | System for sealing percutaneous punctures |
US9386983B2 (en) | 2008-09-23 | 2016-07-12 | Ethicon Endo-Surgery, Llc | Robotically-controlled motorized surgical instrument |
US8210411B2 (en) | 2008-09-23 | 2012-07-03 | Ethicon Endo-Surgery, Inc. | Motor-driven surgical cutting instrument |
US9005230B2 (en) | 2008-09-23 | 2015-04-14 | Ethicon Endo-Surgery, Inc. | Motorized surgical instrument |
US11648005B2 (en) | 2008-09-23 | 2023-05-16 | Cilag Gmbh International | Robotically-controlled motorized surgical instrument with an end effector |
US8608045B2 (en) | 2008-10-10 | 2013-12-17 | Ethicon Endo-Sugery, Inc. | Powered surgical cutting and stapling apparatus with manually retractable firing system |
US8517239B2 (en) | 2009-02-05 | 2013-08-27 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument comprising a magnetic element driver |
BRPI1008667A2 (en) | 2009-02-06 | 2016-03-08 | Ethicom Endo Surgery Inc | improvement of the operated surgical stapler |
US8444036B2 (en) | 2009-02-06 | 2013-05-21 | Ethicon Endo-Surgery, Inc. | Motor driven surgical fastener device with mechanisms for adjusting a tissue gap within the end effector |
US20100246316A1 (en) * | 2009-03-31 | 2010-09-30 | Baxter International Inc. | Dispenser, kit and mixing adapter |
KR20120012811A (en) * | 2009-04-13 | 2012-02-10 | 노오쓰웨스턴 유니버시티 | Novel peptide-based scaffolds for cartilage regeneration and methods for their use |
CA2766229A1 (en) * | 2009-09-08 | 2011-03-17 | Baxter International Inc. | Reconstitution and applicator system for wound sealant product |
US8439929B1 (en) * | 2009-11-09 | 2013-05-14 | Nordson Corporation | Method of preparing a gel matrix for grafting to a bone |
US8851354B2 (en) | 2009-12-24 | 2014-10-07 | Ethicon Endo-Surgery, Inc. | Surgical cutting instrument that analyzes tissue thickness |
US8220688B2 (en) | 2009-12-24 | 2012-07-17 | Ethicon Endo-Surgery, Inc. | Motor-driven surgical cutting instrument with electric actuator directional control assembly |
US8641661B2 (en) * | 2010-01-05 | 2014-02-04 | Baxter International Inc. | Mixing system, kit and mixer adapter |
CA2726566A1 (en) * | 2010-01-11 | 2011-07-11 | Baxter International Inc. | Pipette system, pipette tip assembly and kit |
US9180137B2 (en) | 2010-02-09 | 2015-11-10 | Bone Support Ab | Preparation of bone cement compositions |
US8646674B2 (en) | 2010-05-11 | 2014-02-11 | Ethicon Endo-Surgery, Inc. | Methods and apparatus for delivering tissue treatment compositions to stapled tissue |
US8464925B2 (en) * | 2010-05-11 | 2013-06-18 | Ethicon Endo-Surgery, Inc. | Methods and apparatus for delivering tissue treatment compositions to stapled tissue |
JP6289096B2 (en) | 2010-06-01 | 2018-03-07 | バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated | Process for making a dry and stable hemostatic composition |
CN103037847B (en) * | 2010-06-01 | 2016-01-20 | 巴克斯特国际公司 | For the preparation of the method for dry, stable hemostatic composition |
US8940335B2 (en) | 2010-06-01 | 2015-01-27 | Baxter International Inc. | Process for making dry and stable hemostatic compositions |
US8408250B2 (en) | 2010-06-18 | 2013-04-02 | Warsaw Orthopedic, Inc. | Bone replacement material mixing and delivery devices and methods of use |
US8783543B2 (en) | 2010-07-30 | 2014-07-22 | Ethicon Endo-Surgery, Inc. | Tissue acquisition arrangements and methods for surgical stapling devices |
GB201014514D0 (en) * | 2010-09-01 | 2010-10-13 | Biocomposites Ltd | Mixing and dispensing apparatus for bone void filler |
US11812965B2 (en) | 2010-09-30 | 2023-11-14 | Cilag Gmbh International | Layer of material for a surgical end effector |
US8864009B2 (en) | 2010-09-30 | 2014-10-21 | Ethicon Endo-Surgery, Inc. | Tissue thickness compensator for a surgical stapler comprising an adjustable anvil |
US10945731B2 (en) | 2010-09-30 | 2021-03-16 | Ethicon Llc | Tissue thickness compensator comprising controlled release and expansion |
US9861361B2 (en) | 2010-09-30 | 2018-01-09 | Ethicon Llc | Releasable tissue thickness compensator and fastener cartridge having the same |
US9364233B2 (en) | 2010-09-30 | 2016-06-14 | Ethicon Endo-Surgery, Llc | Tissue thickness compensators for circular surgical staplers |
US9839420B2 (en) | 2010-09-30 | 2017-12-12 | Ethicon Llc | Tissue thickness compensator comprising at least one medicament |
US9232941B2 (en) | 2010-09-30 | 2016-01-12 | Ethicon Endo-Surgery, Inc. | Tissue thickness compensator comprising a reservoir |
US11298125B2 (en) | 2010-09-30 | 2022-04-12 | Cilag Gmbh International | Tissue stapler having a thickness compensator |
US9386988B2 (en) | 2010-09-30 | 2016-07-12 | Ethicon End-Surgery, LLC | Retainer assembly including a tissue thickness compensator |
US11849952B2 (en) | 2010-09-30 | 2023-12-26 | Cilag Gmbh International | Staple cartridge comprising staples positioned within a compressible portion thereof |
US9629814B2 (en) | 2010-09-30 | 2017-04-25 | Ethicon Endo-Surgery, Llc | Tissue thickness compensator configured to redistribute compressive forces |
US8695866B2 (en) | 2010-10-01 | 2014-04-15 | Ethicon Endo-Surgery, Inc. | Surgical instrument having a power control circuit |
US8864708B1 (en) | 2010-12-03 | 2014-10-21 | Medical Device Engineering, LLC. | Tamper indicating closure assembly |
JP2012157818A (en) * | 2011-01-31 | 2012-08-23 | Nokodai Tlo Kk | Reaction apparatus |
LT2699293T (en) | 2011-04-20 | 2019-04-25 | Amgen Inc. | Autoinjector apparatus |
JP6026509B2 (en) | 2011-04-29 | 2016-11-16 | エシコン・エンド−サージェリィ・インコーポレイテッドEthicon Endo−Surgery,Inc. | Staple cartridge including staples disposed within a compressible portion of the staple cartridge itself |
US11207064B2 (en) | 2011-05-27 | 2021-12-28 | Cilag Gmbh International | Automated end effector component reloading system for use with a robotic system |
US9072535B2 (en) | 2011-05-27 | 2015-07-07 | Ethicon Endo-Surgery, Inc. | Surgical stapling instruments with rotatable staple deployment arrangements |
US20130105018A1 (en) * | 2011-10-28 | 2013-05-02 | Medtronic Xomed, Inc. | Turbulence-inducing mixing device |
US9044230B2 (en) | 2012-02-13 | 2015-06-02 | Ethicon Endo-Surgery, Inc. | Surgical cutting and fastening instrument with apparatus for determining cartridge and firing motion status |
EP2822474B1 (en) | 2012-03-06 | 2018-05-02 | Ferrosan Medical Devices A/S | Pressurized container containing haemostatic paste |
BR112014024098B1 (en) | 2012-03-28 | 2021-05-25 | Ethicon Endo-Surgery, Inc. | staple cartridge |
MX353040B (en) | 2012-03-28 | 2017-12-18 | Ethicon Endo Surgery Inc | Retainer assembly including a tissue thickness compensator. |
JP6305979B2 (en) | 2012-03-28 | 2018-04-04 | エシコン・エンド−サージェリィ・インコーポレイテッドEthicon Endo−Surgery,Inc. | Tissue thickness compensator with multiple layers |
US10010311B2 (en) * | 2012-04-11 | 2018-07-03 | St. Jude Medical Puerto Rico Llc | Sealant mixing containers for extra vascular bioadhesive delivery systems and methods |
USD808010S1 (en) | 2012-04-20 | 2018-01-16 | Amgen Inc. | Injection device |
USD898908S1 (en) | 2012-04-20 | 2020-10-13 | Amgen Inc. | Pharmaceutical product cassette for an injection device |
WO2013171310A1 (en) * | 2012-05-16 | 2013-11-21 | Sanofi-Aventis Deutschland Gmbh | Dispense interface |
JP6067007B2 (en) * | 2012-05-30 | 2017-01-25 | 三井化学株式会社 | Three-component adhesive mixing device and three-component adhesive kit |
AU2013275758B2 (en) | 2012-06-12 | 2015-03-12 | Ferrosan Medical Devices A/S | Dry haemostatic composition |
US9101358B2 (en) | 2012-06-15 | 2015-08-11 | Ethicon Endo-Surgery, Inc. | Articulatable surgical instrument comprising a firing drive |
US9289256B2 (en) | 2012-06-28 | 2016-03-22 | Ethicon Endo-Surgery, Llc | Surgical end effectors having angled tissue-contacting surfaces |
US11202631B2 (en) | 2012-06-28 | 2021-12-21 | Cilag Gmbh International | Stapling assembly comprising a firing lockout |
US20140001234A1 (en) | 2012-06-28 | 2014-01-02 | Ethicon Endo-Surgery, Inc. | Coupling arrangements for attaching surgical end effectors to drive systems therefor |
BR112014032776B1 (en) | 2012-06-28 | 2021-09-08 | Ethicon Endo-Surgery, Inc | SURGICAL INSTRUMENT SYSTEM AND SURGICAL KIT FOR USE WITH A SURGICAL INSTRUMENT SYSTEM |
US20140001231A1 (en) | 2012-06-28 | 2014-01-02 | Ethicon Endo-Surgery, Inc. | Firing system lockout arrangements for surgical instruments |
US9649111B2 (en) | 2012-06-28 | 2017-05-16 | Ethicon Endo-Surgery, Llc | Replaceable clip cartridge for a clip applier |
US9204879B2 (en) | 2012-06-28 | 2015-12-08 | Ethicon Endo-Surgery, Inc. | Flexible drive member |
EP2866686A1 (en) | 2012-06-28 | 2015-05-06 | Ethicon Endo-Surgery, Inc. | Empty clip cartridge lockout |
KR102023143B1 (en) * | 2012-11-08 | 2019-09-19 | 술저 믹스팩 아게 | Cartridge for at least two flowable components |
EP2958603B1 (en) | 2013-02-20 | 2018-03-28 | Bone Support AB | Improved setting of hardenable bone substitute |
BR112015021098B1 (en) | 2013-03-01 | 2022-02-15 | Ethicon Endo-Surgery, Inc | COVERAGE FOR A JOINT JOINT AND SURGICAL INSTRUMENT |
JP6345707B2 (en) | 2013-03-01 | 2018-06-20 | エシコン・エンド−サージェリィ・インコーポレイテッドEthicon Endo−Surgery,Inc. | Surgical instrument with soft stop |
US9629629B2 (en) | 2013-03-14 | 2017-04-25 | Ethicon Endo-Surgey, LLC | Control systems for surgical instruments |
US9808244B2 (en) | 2013-03-14 | 2017-11-07 | Ethicon Llc | Sensor arrangements for absolute positioning system for surgical instruments |
JP6336564B2 (en) | 2013-03-15 | 2018-06-06 | アムゲン・インコーポレーテッド | Drug cassette, auto-injector, and auto-injector system |
US10492990B2 (en) | 2013-03-15 | 2019-12-03 | Amgen Inc. | Drug cassette, autoinjector, and autoinjector system |
US9867612B2 (en) | 2013-04-16 | 2018-01-16 | Ethicon Llc | Powered surgical stapler |
BR112015026109B1 (en) | 2013-04-16 | 2022-02-22 | Ethicon Endo-Surgery, Inc | surgical instrument |
AU2014283170B2 (en) | 2013-06-21 | 2017-11-02 | Ferrosan Medical Devices A/S | Vacuum expanded dry composition and syringe for retaining same |
US9775609B2 (en) | 2013-08-23 | 2017-10-03 | Ethicon Llc | Tamper proof circuit for surgical instrument battery pack |
JP6416260B2 (en) | 2013-08-23 | 2018-10-31 | エシコン エルエルシー | Firing member retractor for a powered surgical instrument |
JP6489485B2 (en) | 2013-12-11 | 2019-03-27 | フェロサン メディカル デバイシーズ エイ/エス | Dry composition containing an extrusion enhancing factor |
US10912898B1 (en) | 2014-02-03 | 2021-02-09 | Medical Device Engineering Llc | Tamper evident cap for medical fitting |
US9962161B2 (en) | 2014-02-12 | 2018-05-08 | Ethicon Llc | Deliverable surgical instrument |
US10207099B1 (en) | 2014-02-21 | 2019-02-19 | Patrick Vitello | Closure assembly for medical fitting |
CN106232029B (en) | 2014-02-24 | 2019-04-12 | 伊西康内外科有限责任公司 | Fastening system including firing member locking piece |
US9750499B2 (en) | 2014-03-26 | 2017-09-05 | Ethicon Llc | Surgical stapling instrument system |
US9820738B2 (en) | 2014-03-26 | 2017-11-21 | Ethicon Llc | Surgical instrument comprising interactive systems |
US9826977B2 (en) | 2014-03-26 | 2017-11-28 | Ethicon Llc | Sterilization verification circuit |
BR112016021943B1 (en) | 2014-03-26 | 2022-06-14 | Ethicon Endo-Surgery, Llc | SURGICAL INSTRUMENT FOR USE BY AN OPERATOR IN A SURGICAL PROCEDURE |
US20150297223A1 (en) | 2014-04-16 | 2015-10-22 | Ethicon Endo-Surgery, Inc. | Fastener cartridges including extensions having different configurations |
US10299792B2 (en) | 2014-04-16 | 2019-05-28 | Ethicon Llc | Fastener cartridge comprising non-uniform fasteners |
JP6636452B2 (en) | 2014-04-16 | 2020-01-29 | エシコン エルエルシーEthicon LLC | Fastener cartridge including extension having different configurations |
BR112016023807B1 (en) | 2014-04-16 | 2022-07-12 | Ethicon Endo-Surgery, Llc | CARTRIDGE SET OF FASTENERS FOR USE WITH A SURGICAL INSTRUMENT |
CN106456158B (en) | 2014-04-16 | 2019-02-05 | 伊西康内外科有限责任公司 | Fastener cartridge including non-uniform fastener |
US9801628B2 (en) | 2014-09-26 | 2017-10-31 | Ethicon Llc | Surgical staple and driver arrangements for staple cartridges |
US10166347B1 (en) | 2014-07-18 | 2019-01-01 | Patrick Vitello | Closure assembly for a medical device |
US9820791B2 (en) * | 2014-08-22 | 2017-11-21 | Kyphon SÀRL | Methods of filling bone using bone cement mixing and delivery devices |
US9820792B2 (en) * | 2014-08-22 | 2017-11-21 | Kyphon SÀRL | Bone cement mixing and delivery device |
BR112017004361B1 (en) | 2014-09-05 | 2023-04-11 | Ethicon Llc | ELECTRONIC SYSTEM FOR A SURGICAL INSTRUMENT |
US11311294B2 (en) | 2014-09-05 | 2022-04-26 | Cilag Gmbh International | Powered medical device including measurement of closure state of jaws |
US10016199B2 (en) | 2014-09-05 | 2018-07-10 | Ethicon Llc | Polarity of hall magnet to identify cartridge type |
US10773067B2 (en) | 2014-09-08 | 2020-09-15 | Neomed, Inc. | Enteral connectors having coupling features |
US10105142B2 (en) | 2014-09-18 | 2018-10-23 | Ethicon Llc | Surgical stapler with plurality of cutting elements |
US11523821B2 (en) | 2014-09-26 | 2022-12-13 | Cilag Gmbh International | Method for creating a flexible staple line |
BR112017005981B1 (en) | 2014-09-26 | 2022-09-06 | Ethicon, Llc | ANCHOR MATERIAL FOR USE WITH A SURGICAL STAPLE CARTRIDGE AND SURGICAL STAPLE CARTRIDGE FOR USE WITH A SURGICAL INSTRUMENT |
US10076325B2 (en) | 2014-10-13 | 2018-09-18 | Ethicon Llc | Surgical stapling apparatus comprising a tissue stop |
BR112017007466B1 (en) | 2014-10-13 | 2021-03-02 | Ferrosan Medical Devices A/S | method for preparing a dry composition, method for reconstituting the dry composition, paste, dry composition, container, homeostatic kit, and, using a dry composition |
US9924944B2 (en) | 2014-10-16 | 2018-03-27 | Ethicon Llc | Staple cartridge comprising an adjunct material |
US10517594B2 (en) | 2014-10-29 | 2019-12-31 | Ethicon Llc | Cartridge assemblies for surgical staplers |
US11141153B2 (en) | 2014-10-29 | 2021-10-12 | Cilag Gmbh International | Staple cartridges comprising driver arrangements |
US9844376B2 (en) | 2014-11-06 | 2017-12-19 | Ethicon Llc | Staple cartridge comprising a releasable adjunct material |
US10736636B2 (en) | 2014-12-10 | 2020-08-11 | Ethicon Llc | Articulatable surgical instrument system |
BR112017012996B1 (en) | 2014-12-18 | 2022-11-08 | Ethicon Llc | SURGICAL INSTRUMENT WITH AN ANvil WHICH IS SELECTIVELY MOVABLE ABOUT AN IMMOVABLE GEOMETRIC AXIS DIFFERENT FROM A STAPLE CARTRIDGE |
US10085748B2 (en) | 2014-12-18 | 2018-10-02 | Ethicon Llc | Locking arrangements for detachable shaft assemblies with articulatable surgical end effectors |
US9987000B2 (en) | 2014-12-18 | 2018-06-05 | Ethicon Llc | Surgical instrument assembly comprising a flexible articulation system |
US9943309B2 (en) | 2014-12-18 | 2018-04-17 | Ethicon Llc | Surgical instruments with articulatable end effectors and movable firing beam support arrangements |
US9844374B2 (en) | 2014-12-18 | 2017-12-19 | Ethicon Llc | Surgical instrument systems comprising an articulatable end effector and means for adjusting the firing stroke of a firing member |
US9844375B2 (en) | 2014-12-18 | 2017-12-19 | Ethicon Llc | Drive arrangements for articulatable surgical instruments |
US10188385B2 (en) | 2014-12-18 | 2019-01-29 | Ethicon Llc | Surgical instrument system comprising lockable systems |
US10653837B2 (en) | 2014-12-24 | 2020-05-19 | Ferrosan Medical Devices A/S | Syringe for retaining and mixing first and second substances |
US10300263B1 (en) | 2015-02-27 | 2019-05-28 | Timothy Brandon Hunt | Closure assembly for a medical connector |
US10180463B2 (en) | 2015-02-27 | 2019-01-15 | Ethicon Llc | Surgical apparatus configured to assess whether a performance parameter of the surgical apparatus is within an acceptable performance band |
US9931118B2 (en) | 2015-02-27 | 2018-04-03 | Ethicon Endo-Surgery, Llc | Reinforced battery for a surgical instrument |
US11154301B2 (en) | 2015-02-27 | 2021-10-26 | Cilag Gmbh International | Modular stapling assembly |
US9808246B2 (en) | 2015-03-06 | 2017-11-07 | Ethicon Endo-Surgery, Llc | Method of operating a powered surgical instrument |
US9901342B2 (en) | 2015-03-06 | 2018-02-27 | Ethicon Endo-Surgery, Llc | Signal and power communication system positioned on a rotatable shaft |
JP2020121162A (en) | 2015-03-06 | 2020-08-13 | エシコン エルエルシーEthicon LLC | Time dependent evaluation of sensor data to determine stability element, creep element and viscoelastic element of measurement |
US10245033B2 (en) | 2015-03-06 | 2019-04-02 | Ethicon Llc | Surgical instrument comprising a lockable battery housing |
US10617412B2 (en) | 2015-03-06 | 2020-04-14 | Ethicon Llc | System for detecting the mis-insertion of a staple cartridge into a surgical stapler |
US9993248B2 (en) | 2015-03-06 | 2018-06-12 | Ethicon Endo-Surgery, Llc | Smart sensors with local signal processing |
US10052044B2 (en) | 2015-03-06 | 2018-08-21 | Ethicon Llc | Time dependent evaluation of sensor data to determine stability, creep, and viscoelastic elements of measures |
US9924961B2 (en) | 2015-03-06 | 2018-03-27 | Ethicon Endo-Surgery, Llc | Interactive feedback system for powered surgical instruments |
US10687806B2 (en) | 2015-03-06 | 2020-06-23 | Ethicon Llc | Adaptive tissue compression techniques to adjust closure rates for multiple tissue types |
US10441279B2 (en) | 2015-03-06 | 2019-10-15 | Ethicon Llc | Multiple level thresholds to modify operation of powered surgical instruments |
US10166343B1 (en) | 2015-03-13 | 2019-01-01 | Timothy Brandon Hunt | Noise evident tamper cap |
US10315024B1 (en) | 2015-03-19 | 2019-06-11 | Patick Vitello | Torque limiting closure assembly |
US10213201B2 (en) | 2015-03-31 | 2019-02-26 | Ethicon Llc | Stapling end effector configured to compensate for an uneven gap between a first jaw and a second jaw |
EP3310322B1 (en) | 2015-06-18 | 2020-06-03 | Neomed, Inc. | Syringe-to-syringe male-male coupler |
USD825746S1 (en) | 2015-06-18 | 2018-08-14 | Neomed, Inc. | Syringe-to-syringe coupler |
US10918796B2 (en) | 2015-07-03 | 2021-02-16 | Ferrosan Medical Devices A/S | Syringe for mixing two components and for retaining a vacuum in a storage condition |
US11058425B2 (en) | 2015-08-17 | 2021-07-13 | Ethicon Llc | Implantable layers for a surgical instrument |
US10105139B2 (en) | 2015-09-23 | 2018-10-23 | Ethicon Llc | Surgical stapler having downstream current-based motor control |
US10327769B2 (en) | 2015-09-23 | 2019-06-25 | Ethicon Llc | Surgical stapler having motor control based on a drive system component |
US10238386B2 (en) | 2015-09-23 | 2019-03-26 | Ethicon Llc | Surgical stapler having motor control based on an electrical parameter related to a motor current |
US10363036B2 (en) | 2015-09-23 | 2019-07-30 | Ethicon Llc | Surgical stapler having force-based motor control |
US9572555B1 (en) * | 2015-09-24 | 2017-02-21 | Ethicon, Inc. | Spray or drip tips having multiple outlet channels |
US10299878B2 (en) | 2015-09-25 | 2019-05-28 | Ethicon Llc | Implantable adjunct systems for determining adjunct skew |
US10478188B2 (en) | 2015-09-30 | 2019-11-19 | Ethicon Llc | Implantable layer comprising a constricted configuration |
US11890015B2 (en) | 2015-09-30 | 2024-02-06 | Cilag Gmbh International | Compressible adjunct with crossing spacer fibers |
US10736633B2 (en) | 2015-09-30 | 2020-08-11 | Ethicon Llc | Compressible adjunct with looping members |
US10980539B2 (en) | 2015-09-30 | 2021-04-20 | Ethicon Llc | Implantable adjunct comprising bonded layers |
AU2016353345B2 (en) | 2015-11-12 | 2021-12-23 | University Of Virginia Patent Foundation | Compositions and methods for vas-occlusive contraception and reversal thereof |
US10596069B2 (en) | 2015-12-22 | 2020-03-24 | Ethicon, Inc. | Syringes with mixing chamber in a removable cap |
US10368865B2 (en) | 2015-12-30 | 2019-08-06 | Ethicon Llc | Mechanisms for compensating for drivetrain failure in powered surgical instruments |
US10292704B2 (en) | 2015-12-30 | 2019-05-21 | Ethicon Llc | Mechanisms for compensating for battery pack failure in powered surgical instruments |
US10265068B2 (en) | 2015-12-30 | 2019-04-23 | Ethicon Llc | Surgical instruments with separable motors and motor control circuits |
BR112018016098B1 (en) | 2016-02-09 | 2023-02-23 | Ethicon Llc | SURGICAL INSTRUMENT |
US11213293B2 (en) | 2016-02-09 | 2022-01-04 | Cilag Gmbh International | Articulatable surgical instruments with single articulation link arrangements |
US10245029B2 (en) | 2016-02-09 | 2019-04-02 | Ethicon Llc | Surgical instrument with articulating and axially translatable end effector |
US11224426B2 (en) | 2016-02-12 | 2022-01-18 | Cilag Gmbh International | Mechanisms for compensating for drivetrain failure in powered surgical instruments |
US10448948B2 (en) | 2016-02-12 | 2019-10-22 | Ethicon Llc | Mechanisms for compensating for drivetrain failure in powered surgical instruments |
US10258331B2 (en) | 2016-02-12 | 2019-04-16 | Ethicon Llc | Mechanisms for compensating for drivetrain failure in powered surgical instruments |
EP3419582B1 (en) | 2016-02-24 | 2022-07-13 | Avent, Inc. | Fluid transfer connector |
US11020160B2 (en) * | 2016-03-21 | 2021-06-01 | Warsaw Orthopedic, Inc. | Surgical injection system and method |
US10485542B2 (en) | 2016-04-01 | 2019-11-26 | Ethicon Llc | Surgical stapling instrument comprising multiple lockouts |
US10617413B2 (en) | 2016-04-01 | 2020-04-14 | Ethicon Llc | Closure system arrangements for surgical cutting and stapling devices with separate and distinct firing shafts |
US10828028B2 (en) | 2016-04-15 | 2020-11-10 | Ethicon Llc | Surgical instrument with multiple program responses during a firing motion |
US10492783B2 (en) | 2016-04-15 | 2019-12-03 | Ethicon, Llc | Surgical instrument with improved stop/start control during a firing motion |
US10357247B2 (en) | 2016-04-15 | 2019-07-23 | Ethicon Llc | Surgical instrument with multiple program responses during a firing motion |
US11179150B2 (en) | 2016-04-15 | 2021-11-23 | Cilag Gmbh International | Systems and methods for controlling a surgical stapling and cutting instrument |
US10335145B2 (en) | 2016-04-15 | 2019-07-02 | Ethicon Llc | Modular surgical instrument with configurable operating mode |
US10426467B2 (en) | 2016-04-15 | 2019-10-01 | Ethicon Llc | Surgical instrument with detection sensors |
US11607239B2 (en) | 2016-04-15 | 2023-03-21 | Cilag Gmbh International | Systems and methods for controlling a surgical stapling and cutting instrument |
US10456137B2 (en) | 2016-04-15 | 2019-10-29 | Ethicon Llc | Staple formation detection mechanisms |
US10405859B2 (en) | 2016-04-15 | 2019-09-10 | Ethicon Llc | Surgical instrument with adjustable stop/start control during a firing motion |
US11317917B2 (en) | 2016-04-18 | 2022-05-03 | Cilag Gmbh International | Surgical stapling system comprising a lockable firing assembly |
US10426469B2 (en) | 2016-04-18 | 2019-10-01 | Ethicon Llc | Surgical instrument comprising a primary firing lockout and a secondary firing lockout |
US20170296173A1 (en) | 2016-04-18 | 2017-10-19 | Ethicon Endo-Surgery, Llc | Method for operating a surgical instrument |
US20190223931A1 (en) * | 2016-07-12 | 2019-07-25 | Medmix Systems Ag | Mixing and discharge system for bone replacement material |
US10322235B2 (en) | 2016-09-30 | 2019-06-18 | Thorne Consulting & Intellectual Property, LLC | Multiple chamber syringe piston and mixing devices |
USD833006S1 (en) | 2016-11-28 | 2018-11-06 | Neomed, Inc. | Fluid transfer connector |
US10307548B1 (en) | 2016-12-14 | 2019-06-04 | Timothy Brandon Hunt | Tracking system and method for medical devices |
US11097071B1 (en) | 2016-12-14 | 2021-08-24 | International Medical Industries Inc. | Tamper evident assembly |
CN110099619B (en) | 2016-12-21 | 2022-07-15 | 爱惜康有限责任公司 | Lockout device for surgical end effector and replaceable tool assembly |
US10426471B2 (en) | 2016-12-21 | 2019-10-01 | Ethicon Llc | Surgical instrument with multiple failure response modes |
US10898186B2 (en) | 2016-12-21 | 2021-01-26 | Ethicon Llc | Staple forming pocket arrangements comprising primary sidewalls and pocket sidewalls |
US10758230B2 (en) | 2016-12-21 | 2020-09-01 | Ethicon Llc | Surgical instrument with primary and safety processors |
US10667809B2 (en) | 2016-12-21 | 2020-06-02 | Ethicon Llc | Staple cartridge and staple cartridge channel comprising windows defined therein |
JP7010956B2 (en) | 2016-12-21 | 2022-01-26 | エシコン エルエルシー | How to staple tissue |
US10835245B2 (en) | 2016-12-21 | 2020-11-17 | Ethicon Llc | Method for attaching a shaft assembly to a surgical instrument and, alternatively, to a surgical robot |
US10675026B2 (en) | 2016-12-21 | 2020-06-09 | Ethicon Llc | Methods of stapling tissue |
US10856868B2 (en) | 2016-12-21 | 2020-12-08 | Ethicon Llc | Firing member pin configurations |
US11134942B2 (en) | 2016-12-21 | 2021-10-05 | Cilag Gmbh International | Surgical stapling instruments and staple-forming anvils |
US10568626B2 (en) | 2016-12-21 | 2020-02-25 | Ethicon Llc | Surgical instruments with jaw opening features for increasing a jaw opening distance |
US20180168615A1 (en) | 2016-12-21 | 2018-06-21 | Ethicon Endo-Surgery, Llc | Method of deforming staples from two different types of staple cartridges with the same surgical stapling instrument |
US10568624B2 (en) | 2016-12-21 | 2020-02-25 | Ethicon Llc | Surgical instruments with jaws that are pivotable about a fixed axis and include separate and distinct closure and firing systems |
US10893864B2 (en) | 2016-12-21 | 2021-01-19 | Ethicon | Staple cartridges and arrangements of staples and staple cavities therein |
CN110087565A (en) | 2016-12-21 | 2019-08-02 | 爱惜康有限责任公司 | Surgical stapling system |
US20180168619A1 (en) | 2016-12-21 | 2018-06-21 | Ethicon Endo-Surgery, Llc | Surgical stapling systems |
US11419606B2 (en) | 2016-12-21 | 2022-08-23 | Cilag Gmbh International | Shaft assembly comprising a clutch configured to adapt the output of a rotary firing member to two different systems |
US11160551B2 (en) | 2016-12-21 | 2021-11-02 | Cilag Gmbh International | Articulatable surgical stapling instruments |
US10758229B2 (en) | 2016-12-21 | 2020-09-01 | Ethicon Llc | Surgical instrument comprising improved jaw control |
US10953162B1 (en) | 2016-12-28 | 2021-03-23 | Timothy Brandon Hunt | Tamper evident closure assembly |
EP3565484B1 (en) | 2017-01-05 | 2024-04-03 | Contraline, Inc. | Compositions for implanting and reversing stimuli-responsive implants |
US10758684B1 (en) | 2017-03-03 | 2020-09-01 | Jonathan J. Vitello | Tamper evident assembly |
US11202848B2 (en) | 2017-03-08 | 2021-12-21 | Baxter International Inc. | Surgical adhesive able to glue in wet conditions |
US10912859B2 (en) | 2017-03-08 | 2021-02-09 | Baxter International Inc. | Additive able to provide underwater adhesion |
US11040149B1 (en) | 2017-03-30 | 2021-06-22 | International Medical Industries | Tamper evident closure assembly for a medical device |
US10888672B1 (en) | 2017-04-06 | 2021-01-12 | International Medical Industries, Inc. | Tamper evident closure assembly for a medical device |
US10898659B1 (en) | 2017-05-19 | 2021-01-26 | International Medical Industries Inc. | System for handling and dispensing a plurality of products |
US10933202B1 (en) | 2017-05-19 | 2021-03-02 | International Medical Industries Inc. | Indicator member of low strength resistance for a tamper evident closure |
US10646220B2 (en) | 2017-06-20 | 2020-05-12 | Ethicon Llc | Systems and methods for controlling displacement member velocity for a surgical instrument |
USD879809S1 (en) | 2017-06-20 | 2020-03-31 | Ethicon Llc | Display panel with changeable graphical user interface |
US10881399B2 (en) | 2017-06-20 | 2021-01-05 | Ethicon Llc | Techniques for adaptive control of motor velocity of a surgical stapling and cutting instrument |
USD890784S1 (en) | 2017-06-20 | 2020-07-21 | Ethicon Llc | Display panel with changeable graphical user interface |
USD879808S1 (en) | 2017-06-20 | 2020-03-31 | Ethicon Llc | Display panel with graphical user interface |
US10327767B2 (en) | 2017-06-20 | 2019-06-25 | Ethicon Llc | Control of motor velocity of a surgical stapling and cutting instrument based on angle of articulation |
US10888321B2 (en) | 2017-06-20 | 2021-01-12 | Ethicon Llc | Systems and methods for controlling velocity of a displacement member of a surgical stapling and cutting instrument |
US11071554B2 (en) | 2017-06-20 | 2021-07-27 | Cilag Gmbh International | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on magnitude of velocity error measurements |
US11090046B2 (en) | 2017-06-20 | 2021-08-17 | Cilag Gmbh International | Systems and methods for controlling displacement member motion of a surgical stapling and cutting instrument |
US10368864B2 (en) | 2017-06-20 | 2019-08-06 | Ethicon Llc | Systems and methods for controlling displaying motor velocity for a surgical instrument |
US11517325B2 (en) | 2017-06-20 | 2022-12-06 | Cilag Gmbh International | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured displacement distance traveled over a specified time interval |
US10390841B2 (en) | 2017-06-20 | 2019-08-27 | Ethicon Llc | Control of motor velocity of a surgical stapling and cutting instrument based on angle of articulation |
US11382638B2 (en) | 2017-06-20 | 2022-07-12 | Cilag Gmbh International | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured time over a specified displacement distance |
US10779820B2 (en) | 2017-06-20 | 2020-09-22 | Ethicon Llc | Systems and methods for controlling motor speed according to user input for a surgical instrument |
US10624633B2 (en) | 2017-06-20 | 2020-04-21 | Ethicon Llc | Systems and methods for controlling motor velocity of a surgical stapling and cutting instrument |
US10307170B2 (en) | 2017-06-20 | 2019-06-04 | Ethicon Llc | Method for closed loop control of motor velocity of a surgical stapling and cutting instrument |
US10980537B2 (en) | 2017-06-20 | 2021-04-20 | Ethicon Llc | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured time over a specified number of shaft rotations |
US11653914B2 (en) | 2017-06-20 | 2023-05-23 | Cilag Gmbh International | Systems and methods for controlling motor velocity of a surgical stapling and cutting instrument according to articulation angle of end effector |
US10813639B2 (en) | 2017-06-20 | 2020-10-27 | Ethicon Llc | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on system conditions |
US10881396B2 (en) | 2017-06-20 | 2021-01-05 | Ethicon Llc | Surgical instrument with variable duration trigger arrangement |
US11266405B2 (en) | 2017-06-27 | 2022-03-08 | Cilag Gmbh International | Surgical anvil manufacturing methods |
US10772629B2 (en) | 2017-06-27 | 2020-09-15 | Ethicon Llc | Surgical anvil arrangements |
US11324503B2 (en) | 2017-06-27 | 2022-05-10 | Cilag Gmbh International | Surgical firing member arrangements |
US10993716B2 (en) | 2017-06-27 | 2021-05-04 | Ethicon Llc | Surgical anvil arrangements |
US10856869B2 (en) | 2017-06-27 | 2020-12-08 | Ethicon Llc | Surgical anvil arrangements |
US11141154B2 (en) | 2017-06-27 | 2021-10-12 | Cilag Gmbh International | Surgical end effectors and anvils |
EP4070740A1 (en) | 2017-06-28 | 2022-10-12 | Cilag GmbH International | Surgical instrument comprising selectively actuatable rotatable couplers |
US11246592B2 (en) | 2017-06-28 | 2022-02-15 | Cilag Gmbh International | Surgical instrument comprising an articulation system lockable to a frame |
US11058424B2 (en) | 2017-06-28 | 2021-07-13 | Cilag Gmbh International | Surgical instrument comprising an offset articulation joint |
USD851762S1 (en) | 2017-06-28 | 2019-06-18 | Ethicon Llc | Anvil |
US10765427B2 (en) | 2017-06-28 | 2020-09-08 | Ethicon Llc | Method for articulating a surgical instrument |
US10211586B2 (en) | 2017-06-28 | 2019-02-19 | Ethicon Llc | Surgical shaft assemblies with watertight housings |
USD854151S1 (en) | 2017-06-28 | 2019-07-16 | Ethicon Llc | Surgical instrument shaft |
US11564686B2 (en) | 2017-06-28 | 2023-01-31 | Cilag Gmbh International | Surgical shaft assemblies with flexible interfaces |
US10903685B2 (en) | 2017-06-28 | 2021-01-26 | Ethicon Llc | Surgical shaft assemblies with slip ring assemblies forming capacitive channels |
US11259805B2 (en) | 2017-06-28 | 2022-03-01 | Cilag Gmbh International | Surgical instrument comprising firing member supports |
USD869655S1 (en) | 2017-06-28 | 2019-12-10 | Ethicon Llc | Surgical fastener cartridge |
USD906355S1 (en) | 2017-06-28 | 2020-12-29 | Ethicon Llc | Display screen or portion thereof with a graphical user interface for a surgical instrument |
US10588633B2 (en) | 2017-06-28 | 2020-03-17 | Ethicon Llc | Surgical instruments with open and closable jaws and axially movable firing member that is initially parked in close proximity to the jaws prior to firing |
US10716614B2 (en) | 2017-06-28 | 2020-07-21 | Ethicon Llc | Surgical shaft assemblies with slip ring assemblies with increased contact pressure |
US11007022B2 (en) | 2017-06-29 | 2021-05-18 | Ethicon Llc | Closed loop velocity control techniques based on sensed tissue parameters for robotic surgical instrument |
US10398434B2 (en) | 2017-06-29 | 2019-09-03 | Ethicon Llc | Closed loop velocity control of closure member for robotic surgical instrument |
US10258418B2 (en) | 2017-06-29 | 2019-04-16 | Ethicon Llc | System for controlling articulation forces |
US10898183B2 (en) | 2017-06-29 | 2021-01-26 | Ethicon Llc | Robotic surgical instrument with closed loop feedback techniques for advancement of closure member during firing |
US10932772B2 (en) | 2017-06-29 | 2021-03-02 | Ethicon Llc | Methods for closed loop velocity control for robotic surgical instrument |
US11944300B2 (en) | 2017-08-03 | 2024-04-02 | Cilag Gmbh International | Method for operating a surgical system bailout |
US11304695B2 (en) | 2017-08-03 | 2022-04-19 | Cilag Gmbh International | Surgical system shaft interconnection |
US11471155B2 (en) | 2017-08-03 | 2022-10-18 | Cilag Gmbh International | Surgical system bailout |
US10765429B2 (en) | 2017-09-29 | 2020-09-08 | Ethicon Llc | Systems and methods for providing alerts according to the operational state of a surgical instrument |
US10743872B2 (en) | 2017-09-29 | 2020-08-18 | Ethicon Llc | System and methods for controlling a display of a surgical instrument |
USD907648S1 (en) | 2017-09-29 | 2021-01-12 | Ethicon Llc | Display screen or portion thereof with animated graphical user interface |
USD917500S1 (en) | 2017-09-29 | 2021-04-27 | Ethicon Llc | Display screen or portion thereof with graphical user interface |
US10796471B2 (en) | 2017-09-29 | 2020-10-06 | Ethicon Llc | Systems and methods of displaying a knife position for a surgical instrument |
US10729501B2 (en) | 2017-09-29 | 2020-08-04 | Ethicon Llc | Systems and methods for language selection of a surgical instrument |
USD907647S1 (en) | 2017-09-29 | 2021-01-12 | Ethicon Llc | Display screen or portion thereof with animated graphical user interface |
US11399829B2 (en) | 2017-09-29 | 2022-08-02 | Cilag Gmbh International | Systems and methods of initiating a power shutdown mode for a surgical instrument |
US11090075B2 (en) | 2017-10-30 | 2021-08-17 | Cilag Gmbh International | Articulation features for surgical end effector |
US11134944B2 (en) | 2017-10-30 | 2021-10-05 | Cilag Gmbh International | Surgical stapler knife motion controls |
US10779903B2 (en) | 2017-10-31 | 2020-09-22 | Ethicon Llc | Positive shaft rotation lock activated by jaw closure |
US10842490B2 (en) | 2017-10-31 | 2020-11-24 | Ethicon Llc | Cartridge body design with force reduction based on firing completion |
US10828033B2 (en) | 2017-12-15 | 2020-11-10 | Ethicon Llc | Handheld electromechanical surgical instruments with improved motor control arrangements for positioning components of an adapter coupled thereto |
US10779826B2 (en) | 2017-12-15 | 2020-09-22 | Ethicon Llc | Methods of operating surgical end effectors |
US11197670B2 (en) | 2017-12-15 | 2021-12-14 | Cilag Gmbh International | Surgical end effectors with pivotal jaws configured to touch at their respective distal ends when fully closed |
US10966718B2 (en) | 2017-12-15 | 2021-04-06 | Ethicon Llc | Dynamic clamping assemblies with improved wear characteristics for use in connection with electromechanical surgical instruments |
US10743874B2 (en) | 2017-12-15 | 2020-08-18 | Ethicon Llc | Sealed adapters for use with electromechanical surgical instruments |
US10687813B2 (en) | 2017-12-15 | 2020-06-23 | Ethicon Llc | Adapters with firing stroke sensing arrangements for use in connection with electromechanical surgical instruments |
US10869666B2 (en) | 2017-12-15 | 2020-12-22 | Ethicon Llc | Adapters with control systems for controlling multiple motors of an electromechanical surgical instrument |
US11071543B2 (en) | 2017-12-15 | 2021-07-27 | Cilag Gmbh International | Surgical end effectors with clamping assemblies configured to increase jaw aperture ranges |
US11033267B2 (en) | 2017-12-15 | 2021-06-15 | Ethicon Llc | Systems and methods of controlling a clamping member firing rate of a surgical instrument |
US10779825B2 (en) | 2017-12-15 | 2020-09-22 | Ethicon Llc | Adapters with end effector position sensing and control arrangements for use in connection with electromechanical surgical instruments |
US10743875B2 (en) | 2017-12-15 | 2020-08-18 | Ethicon Llc | Surgical end effectors with jaw stiffener arrangements configured to permit monitoring of firing member |
US11006955B2 (en) | 2017-12-15 | 2021-05-18 | Ethicon Llc | End effectors with positive jaw opening features for use with adapters for electromechanical surgical instruments |
US11045270B2 (en) | 2017-12-19 | 2021-06-29 | Cilag Gmbh International | Robotic attachment comprising exterior drive actuator |
US10835330B2 (en) | 2017-12-19 | 2020-11-17 | Ethicon Llc | Method for determining the position of a rotatable jaw of a surgical instrument attachment assembly |
US10729509B2 (en) | 2017-12-19 | 2020-08-04 | Ethicon Llc | Surgical instrument comprising closure and firing locking mechanism |
US10716565B2 (en) | 2017-12-19 | 2020-07-21 | Ethicon Llc | Surgical instruments with dual articulation drivers |
US11020112B2 (en) | 2017-12-19 | 2021-06-01 | Ethicon Llc | Surgical tools configured for interchangeable use with different controller interfaces |
USD910847S1 (en) | 2017-12-19 | 2021-02-16 | Ethicon Llc | Surgical instrument assembly |
US11541180B1 (en) | 2017-12-21 | 2023-01-03 | Patrick Vitello | Closure assembly having a snap-fit construction |
US11311290B2 (en) | 2017-12-21 | 2022-04-26 | Cilag Gmbh International | Surgical instrument comprising an end effector dampener |
US11583274B2 (en) | 2017-12-21 | 2023-02-21 | Cilag Gmbh International | Self-guiding stapling instrument |
US11076853B2 (en) | 2017-12-21 | 2021-08-03 | Cilag Gmbh International | Systems and methods of displaying a knife position during transection for a surgical instrument |
US11129680B2 (en) | 2017-12-21 | 2021-09-28 | Cilag Gmbh International | Surgical instrument comprising a projector |
US11278681B1 (en) | 2018-02-20 | 2022-03-22 | Robert Banik | Tamper evident adaptor closure |
US11413406B1 (en) | 2018-03-05 | 2022-08-16 | Jonathan J. Vitello | Tamper evident assembly |
AU2019266529A1 (en) | 2018-05-09 | 2020-12-03 | Ethicon Inc. | Method for preparing a haemostatic composition |
EP3572102B1 (en) * | 2018-05-21 | 2021-02-24 | OssDsign AB | Two-paste cement-forming compositions |
US20190388625A1 (en) | 2018-06-15 | 2019-12-26 | James T. Doubet | Syringe adapter for medication |
USD890925S1 (en) | 2018-06-15 | 2020-07-21 | James T. Doubet | Syringe adapter for medication |
US11857751B1 (en) | 2018-07-02 | 2024-01-02 | International Medical Industries Inc. | Assembly for a medical connector |
US11779520B1 (en) | 2018-07-02 | 2023-10-10 | Patrick Vitello | Closure for a medical dispenser including a one-piece tip cap |
US11793987B1 (en) | 2018-07-02 | 2023-10-24 | Patrick Vitello | Flex tec closure assembly for a medical dispenser |
US11690994B1 (en) | 2018-07-13 | 2023-07-04 | Robert Banik | Modular medical connector |
US10912559B2 (en) | 2018-08-20 | 2021-02-09 | Ethicon Llc | Reinforced deformable anvil tip for surgical stapler anvil |
US11207065B2 (en) | 2018-08-20 | 2021-12-28 | Cilag Gmbh International | Method for fabricating surgical stapler anvils |
US11324501B2 (en) | 2018-08-20 | 2022-05-10 | Cilag Gmbh International | Surgical stapling devices with improved closure members |
US10856870B2 (en) | 2018-08-20 | 2020-12-08 | Ethicon Llc | Switching arrangements for motor powered articulatable surgical instruments |
US11045192B2 (en) | 2018-08-20 | 2021-06-29 | Cilag Gmbh International | Fabricating techniques for surgical stapler anvils |
US11083458B2 (en) | 2018-08-20 | 2021-08-10 | Cilag Gmbh International | Powered surgical instruments with clutching arrangements to convert linear drive motions to rotary drive motions |
US10842492B2 (en) | 2018-08-20 | 2020-11-24 | Ethicon Llc | Powered articulatable surgical instruments with clutching and locking arrangements for linking an articulation drive system to a firing drive system |
US11039834B2 (en) | 2018-08-20 | 2021-06-22 | Cilag Gmbh International | Surgical stapler anvils with staple directing protrusions and tissue stability features |
US11253256B2 (en) | 2018-08-20 | 2022-02-22 | Cilag Gmbh International | Articulatable motor powered surgical instruments with dedicated articulation motor arrangements |
USD914878S1 (en) | 2018-08-20 | 2021-03-30 | Ethicon Llc | Surgical instrument anvil |
US10779821B2 (en) | 2018-08-20 | 2020-09-22 | Ethicon Llc | Surgical stapler anvils with tissue stop features configured to avoid tissue pinch |
US11291440B2 (en) | 2018-08-20 | 2022-04-05 | Cilag Gmbh International | Method for operating a powered articulatable surgical instrument |
US11426328B1 (en) | 2018-08-31 | 2022-08-30 | Alexander Ollmann | Closure for a medical container |
USD948713S1 (en) | 2019-09-03 | 2022-04-12 | International Medical Industries, Inc. | Asymmetrical self righting tip cap |
US11471610B1 (en) | 2018-10-18 | 2022-10-18 | Robert Banik | Asymmetrical closure for a medical device |
CA3117577A1 (en) | 2018-11-13 | 2020-05-22 | Contraline, Inc. | Systems and methods for delivering biomaterials |
USD903865S1 (en) | 2018-11-19 | 2020-12-01 | International Medical Industries, Inc. | Self-righting tip cap |
US11147551B2 (en) | 2019-03-25 | 2021-10-19 | Cilag Gmbh International | Firing drive arrangements for surgical systems |
US11172929B2 (en) | 2019-03-25 | 2021-11-16 | Cilag Gmbh International | Articulation drive arrangements for surgical systems |
US11147553B2 (en) | 2019-03-25 | 2021-10-19 | Cilag Gmbh International | Firing drive arrangements for surgical systems |
US11696761B2 (en) | 2019-03-25 | 2023-07-11 | Cilag Gmbh International | Firing drive arrangements for surgical systems |
US11432816B2 (en) | 2019-04-30 | 2022-09-06 | Cilag Gmbh International | Articulation pin for a surgical instrument |
US11426251B2 (en) | 2019-04-30 | 2022-08-30 | Cilag Gmbh International | Articulation directional lights on a surgical instrument |
US11471157B2 (en) | 2019-04-30 | 2022-10-18 | Cilag Gmbh International | Articulation control mapping for a surgical instrument |
US11648009B2 (en) | 2019-04-30 | 2023-05-16 | Cilag Gmbh International | Rotatable jaw tip for a surgical instrument |
US11253254B2 (en) | 2019-04-30 | 2022-02-22 | Cilag Gmbh International | Shaft rotation actuator on a surgical instrument |
US11452528B2 (en) | 2019-04-30 | 2022-09-27 | Cilag Gmbh International | Articulation actuators for a surgical instrument |
US11903581B2 (en) | 2019-04-30 | 2024-02-20 | Cilag Gmbh International | Methods for stapling tissue using a surgical instrument |
US11376098B2 (en) | 2019-06-28 | 2022-07-05 | Cilag Gmbh International | Surgical instrument system comprising an RFID system |
US11627959B2 (en) | 2019-06-28 | 2023-04-18 | Cilag Gmbh International | Surgical instruments including manual and powered system lockouts |
US11259803B2 (en) | 2019-06-28 | 2022-03-01 | Cilag Gmbh International | Surgical stapling system having an information encryption protocol |
US11660163B2 (en) | 2019-06-28 | 2023-05-30 | Cilag Gmbh International | Surgical system with RFID tags for updating motor assembly parameters |
US11224497B2 (en) | 2019-06-28 | 2022-01-18 | Cilag Gmbh International | Surgical systems with multiple RFID tags |
US11298127B2 (en) | 2019-06-28 | 2022-04-12 | Cilag GmbH Interational | Surgical stapling system having a lockout mechanism for an incompatible cartridge |
US11426167B2 (en) | 2019-06-28 | 2022-08-30 | Cilag Gmbh International | Mechanisms for proper anvil attachment surgical stapling head assembly |
US11246678B2 (en) | 2019-06-28 | 2022-02-15 | Cilag Gmbh International | Surgical stapling system having a frangible RFID tag |
US11523822B2 (en) | 2019-06-28 | 2022-12-13 | Cilag Gmbh International | Battery pack including a circuit interrupter |
US11684434B2 (en) | 2019-06-28 | 2023-06-27 | Cilag Gmbh International | Surgical RFID assemblies for instrument operational setting control |
US11291451B2 (en) | 2019-06-28 | 2022-04-05 | Cilag Gmbh International | Surgical instrument with battery compatibility verification functionality |
US11771419B2 (en) | 2019-06-28 | 2023-10-03 | Cilag Gmbh International | Packaging for a replaceable component of a surgical stapling system |
US11399837B2 (en) | 2019-06-28 | 2022-08-02 | Cilag Gmbh International | Mechanisms for motor control adjustments of a motorized surgical instrument |
US11553971B2 (en) | 2019-06-28 | 2023-01-17 | Cilag Gmbh International | Surgical RFID assemblies for display and communication |
US11051807B2 (en) | 2019-06-28 | 2021-07-06 | Cilag Gmbh International | Packaging assembly including a particulate trap |
US11638587B2 (en) | 2019-06-28 | 2023-05-02 | Cilag Gmbh International | RFID identification systems for surgical instruments |
US11241235B2 (en) | 2019-06-28 | 2022-02-08 | Cilag Gmbh International | Method of using multiple RFID chips with a surgical assembly |
US11464601B2 (en) | 2019-06-28 | 2022-10-11 | Cilag Gmbh International | Surgical instrument comprising an RFID system for tracking a movable component |
US11219455B2 (en) | 2019-06-28 | 2022-01-11 | Cilag Gmbh International | Surgical instrument including a lockout key |
US11497492B2 (en) | 2019-06-28 | 2022-11-15 | Cilag Gmbh International | Surgical instrument including an articulation lock |
US11478241B2 (en) | 2019-06-28 | 2022-10-25 | Cilag Gmbh International | Staple cartridge including projections |
US11298132B2 (en) | 2019-06-28 | 2022-04-12 | Cilag GmbH Inlernational | Staple cartridge including a honeycomb extension |
US11911339B1 (en) | 2019-08-15 | 2024-02-27 | Peter Lehel | Universal additive port cap |
US11697527B1 (en) | 2019-09-11 | 2023-07-11 | Logan Hendren | Tamper evident closure assembly |
US11357588B1 (en) | 2019-11-25 | 2022-06-14 | Patrick Vitello | Needle packaging and disposal assembly |
US11911032B2 (en) | 2019-12-19 | 2024-02-27 | Cilag Gmbh International | Staple cartridge comprising a seating cam |
US11931033B2 (en) | 2019-12-19 | 2024-03-19 | Cilag Gmbh International | Staple cartridge comprising a latch lockout |
US11446029B2 (en) | 2019-12-19 | 2022-09-20 | Cilag Gmbh International | Staple cartridge comprising projections extending from a curved deck surface |
US11607219B2 (en) | 2019-12-19 | 2023-03-21 | Cilag Gmbh International | Staple cartridge comprising a detachable tissue cutting knife |
US11701111B2 (en) | 2019-12-19 | 2023-07-18 | Cilag Gmbh International | Method for operating a surgical stapling instrument |
US11464512B2 (en) | 2019-12-19 | 2022-10-11 | Cilag Gmbh International | Staple cartridge comprising a curved deck surface |
US11529137B2 (en) | 2019-12-19 | 2022-12-20 | Cilag Gmbh International | Staple cartridge comprising driver retention members |
US11504122B2 (en) | 2019-12-19 | 2022-11-22 | Cilag Gmbh International | Surgical instrument comprising a nested firing member |
US11559304B2 (en) | 2019-12-19 | 2023-01-24 | Cilag Gmbh International | Surgical instrument comprising a rapid closure mechanism |
US11304696B2 (en) | 2019-12-19 | 2022-04-19 | Cilag Gmbh International | Surgical instrument comprising a powered articulation system |
US11234698B2 (en) | 2019-12-19 | 2022-02-01 | Cilag Gmbh International | Stapling system comprising a clamp lockout and a firing lockout |
US11844520B2 (en) | 2019-12-19 | 2023-12-19 | Cilag Gmbh International | Staple cartridge comprising driver retention members |
US11291447B2 (en) | 2019-12-19 | 2022-04-05 | Cilag Gmbh International | Stapling instrument comprising independent jaw closing and staple firing systems |
US11529139B2 (en) | 2019-12-19 | 2022-12-20 | Cilag Gmbh International | Motor driven surgical instrument |
US11576672B2 (en) | 2019-12-19 | 2023-02-14 | Cilag Gmbh International | Surgical instrument comprising a closure system including a closure member and an opening member driven by a drive screw |
US11904149B1 (en) | 2020-02-18 | 2024-02-20 | Jonathan Vitello | Oral tamper evident closure with retained indicator |
USD974560S1 (en) | 2020-06-02 | 2023-01-03 | Cilag Gmbh International | Staple cartridge |
USD975850S1 (en) | 2020-06-02 | 2023-01-17 | Cilag Gmbh International | Staple cartridge |
USD967421S1 (en) | 2020-06-02 | 2022-10-18 | Cilag Gmbh International | Staple cartridge |
USD966512S1 (en) | 2020-06-02 | 2022-10-11 | Cilag Gmbh International | Staple cartridge |
USD975278S1 (en) | 2020-06-02 | 2023-01-10 | Cilag Gmbh International | Staple cartridge |
USD975851S1 (en) | 2020-06-02 | 2023-01-17 | Cilag Gmbh International | Staple cartridge |
USD976401S1 (en) | 2020-06-02 | 2023-01-24 | Cilag Gmbh International | Staple cartridge |
US20220031320A1 (en) | 2020-07-28 | 2022-02-03 | Cilag Gmbh International | Surgical instruments with flexible firing member actuator constraint arrangements |
US11523970B1 (en) | 2020-08-28 | 2022-12-13 | Jonathan Vitello | Tamper evident shield |
US11452526B2 (en) | 2020-10-29 | 2022-09-27 | Cilag Gmbh International | Surgical instrument comprising a staged voltage regulation start-up system |
US11617577B2 (en) | 2020-10-29 | 2023-04-04 | Cilag Gmbh International | Surgical instrument comprising a sensor configured to sense whether an articulation drive of the surgical instrument is actuatable |
US11517390B2 (en) | 2020-10-29 | 2022-12-06 | Cilag Gmbh International | Surgical instrument comprising a limited travel switch |
US11717289B2 (en) | 2020-10-29 | 2023-08-08 | Cilag Gmbh International | Surgical instrument comprising an indicator which indicates that an articulation drive is actuatable |
USD1013170S1 (en) | 2020-10-29 | 2024-01-30 | Cilag Gmbh International | Surgical instrument assembly |
US11779330B2 (en) | 2020-10-29 | 2023-10-10 | Cilag Gmbh International | Surgical instrument comprising a jaw alignment system |
US11844518B2 (en) | 2020-10-29 | 2023-12-19 | Cilag Gmbh International | Method for operating a surgical instrument |
USD980425S1 (en) | 2020-10-29 | 2023-03-07 | Cilag Gmbh International | Surgical instrument assembly |
US11931025B2 (en) | 2020-10-29 | 2024-03-19 | Cilag Gmbh International | Surgical instrument comprising a releasable closure drive lock |
US11534259B2 (en) | 2020-10-29 | 2022-12-27 | Cilag Gmbh International | Surgical instrument comprising an articulation indicator |
US11896217B2 (en) | 2020-10-29 | 2024-02-13 | Cilag Gmbh International | Surgical instrument comprising an articulation lock |
US20220143561A1 (en) * | 2020-11-12 | 2022-05-12 | The Procter & Gamble Company | Positive displacement mixer |
US11653920B2 (en) | 2020-12-02 | 2023-05-23 | Cilag Gmbh International | Powered surgical instruments with communication interfaces through sterile barrier |
US11653915B2 (en) | 2020-12-02 | 2023-05-23 | Cilag Gmbh International | Surgical instruments with sled location detection and adjustment features |
US11890010B2 (en) | 2020-12-02 | 2024-02-06 | Cllag GmbH International | Dual-sided reinforced reload for surgical instruments |
US11627960B2 (en) | 2020-12-02 | 2023-04-18 | Cilag Gmbh International | Powered surgical instruments with smart reload with separately attachable exteriorly mounted wiring connections |
US11944296B2 (en) | 2020-12-02 | 2024-04-02 | Cilag Gmbh International | Powered surgical instruments with external connectors |
US11678882B2 (en) | 2020-12-02 | 2023-06-20 | Cilag Gmbh International | Surgical instruments with interactive features to remedy incidental sled movements |
US11744581B2 (en) | 2020-12-02 | 2023-09-05 | Cilag Gmbh International | Powered surgical instruments with multi-phase tissue treatment |
US11737751B2 (en) | 2020-12-02 | 2023-08-29 | Cilag Gmbh International | Devices and methods of managing energy dissipated within sterile barriers of surgical instrument housings |
US11849943B2 (en) | 2020-12-02 | 2023-12-26 | Cilag Gmbh International | Surgical instrument with cartridge release mechanisms |
US11872187B1 (en) | 2020-12-28 | 2024-01-16 | Jonathan Vitello | Tamper evident seal for a vial cover |
US20220241152A1 (en) * | 2021-02-02 | 2022-08-04 | Freedom Corp. | Fibrin biopolymer formation and application device |
US11950777B2 (en) | 2021-02-26 | 2024-04-09 | Cilag Gmbh International | Staple cartridge comprising an information access control system |
US11723657B2 (en) | 2021-02-26 | 2023-08-15 | Cilag Gmbh International | Adjustable communication based on available bandwidth and power capacity |
US11793514B2 (en) | 2021-02-26 | 2023-10-24 | Cilag Gmbh International | Staple cartridge comprising sensor array which may be embedded in cartridge body |
US11749877B2 (en) | 2021-02-26 | 2023-09-05 | Cilag Gmbh International | Stapling instrument comprising a signal antenna |
US11751869B2 (en) | 2021-02-26 | 2023-09-12 | Cilag Gmbh International | Monitoring of multiple sensors over time to detect moving characteristics of tissue |
US11701113B2 (en) | 2021-02-26 | 2023-07-18 | Cilag Gmbh International | Stapling instrument comprising a separate power antenna and a data transfer antenna |
US11744583B2 (en) | 2021-02-26 | 2023-09-05 | Cilag Gmbh International | Distal communication array to tune frequency of RF systems |
US11950779B2 (en) | 2021-02-26 | 2024-04-09 | Cilag Gmbh International | Method of powering and communicating with a staple cartridge |
US11730473B2 (en) | 2021-02-26 | 2023-08-22 | Cilag Gmbh International | Monitoring of manufacturing life-cycle |
US11696757B2 (en) | 2021-02-26 | 2023-07-11 | Cilag Gmbh International | Monitoring of internal systems to detect and track cartridge motion status |
US11925349B2 (en) | 2021-02-26 | 2024-03-12 | Cilag Gmbh International | Adjustment to transfer parameters to improve available power |
US11812964B2 (en) | 2021-02-26 | 2023-11-14 | Cilag Gmbh International | Staple cartridge comprising a power management circuit |
US11826042B2 (en) | 2021-03-22 | 2023-11-28 | Cilag Gmbh International | Surgical instrument comprising a firing drive including a selectable leverage mechanism |
US11806011B2 (en) | 2021-03-22 | 2023-11-07 | Cilag Gmbh International | Stapling instrument comprising tissue compression systems |
US11759202B2 (en) | 2021-03-22 | 2023-09-19 | Cilag Gmbh International | Staple cartridge comprising an implantable layer |
US11717291B2 (en) | 2021-03-22 | 2023-08-08 | Cilag Gmbh International | Staple cartridge comprising staples configured to apply different tissue compression |
US11737749B2 (en) | 2021-03-22 | 2023-08-29 | Cilag Gmbh International | Surgical stapling instrument comprising a retraction system |
US11723658B2 (en) | 2021-03-22 | 2023-08-15 | Cilag Gmbh International | Staple cartridge comprising a firing lockout |
US11826012B2 (en) | 2021-03-22 | 2023-11-28 | Cilag Gmbh International | Stapling instrument comprising a pulsed motor-driven firing rack |
US11793516B2 (en) | 2021-03-24 | 2023-10-24 | Cilag Gmbh International | Surgical staple cartridge comprising longitudinal support beam |
US11857183B2 (en) | 2021-03-24 | 2024-01-02 | Cilag Gmbh International | Stapling assembly components having metal substrates and plastic bodies |
US11903582B2 (en) | 2021-03-24 | 2024-02-20 | Cilag Gmbh International | Leveraging surfaces for cartridge installation |
US11849945B2 (en) | 2021-03-24 | 2023-12-26 | Cilag Gmbh International | Rotary-driven surgical stapling assembly comprising eccentrically driven firing member |
US11896219B2 (en) | 2021-03-24 | 2024-02-13 | Cilag Gmbh International | Mating features between drivers and underside of a cartridge deck |
US11786239B2 (en) | 2021-03-24 | 2023-10-17 | Cilag Gmbh International | Surgical instrument articulation joint arrangements comprising multiple moving linkage features |
US11849944B2 (en) | 2021-03-24 | 2023-12-26 | Cilag Gmbh International | Drivers for fastener cartridge assemblies having rotary drive screws |
US11896218B2 (en) | 2021-03-24 | 2024-02-13 | Cilag Gmbh International | Method of using a powered stapling device |
US11786243B2 (en) | 2021-03-24 | 2023-10-17 | Cilag Gmbh International | Firing members having flexible portions for adapting to a load during a surgical firing stroke |
US11944336B2 (en) | 2021-03-24 | 2024-04-02 | Cilag Gmbh International | Joint arrangements for multi-planar alignment and support of operational drive shafts in articulatable surgical instruments |
US11744603B2 (en) | 2021-03-24 | 2023-09-05 | Cilag Gmbh International | Multi-axis pivot joints for surgical instruments and methods for manufacturing same |
US11832816B2 (en) | 2021-03-24 | 2023-12-05 | Cilag Gmbh International | Surgical stapling assembly comprising nonplanar staples and planar staples |
US11826047B2 (en) | 2021-05-28 | 2023-11-28 | Cilag Gmbh International | Stapling instrument comprising jaw mounts |
US11877745B2 (en) | 2021-10-18 | 2024-01-23 | Cilag Gmbh International | Surgical stapling assembly having longitudinally-repeating staple leg clusters |
US11957337B2 (en) | 2021-10-18 | 2024-04-16 | Cilag Gmbh International | Surgical stapling assembly with offset ramped drive surfaces |
US11937816B2 (en) | 2021-10-28 | 2024-03-26 | Cilag Gmbh International | Electrical lead arrangements for surgical instruments |
CN114669227B (en) * | 2022-03-24 | 2023-03-31 | 奥精医疗科技股份有限公司 | Preparation method of bone cement |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4061787A (en) | 1976-03-15 | 1977-12-06 | Union Carbide Corporation | Collagen compositions having crosslinking agent incorporated therein and the method of preparing the same |
US5643464A (en) | 1988-11-21 | 1997-07-01 | Collagen Corporation | Process for preparing a sterile, dry crosslinking agent |
US6007613A (en) | 1994-11-03 | 1999-12-28 | Fusion Medical Technologies, Inc. | Bioadhesive; preparation procedure and device for the application of a bioadhesive; and hardeners for a bioadhesive |
US6063061A (en) | 1996-08-27 | 2000-05-16 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
US6066325A (en) | 1996-08-27 | 2000-05-23 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
US6165489A (en) | 1994-11-23 | 2000-12-26 | Cohesion Technologies, Inc. | Crosslinked collagen compositions for in situ administration |
US6395307B1 (en) | 1997-04-30 | 2002-05-28 | Reckitt Benckiser (Uk) Limited | Pourable alginate compositions |
Family Cites Families (158)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2533004A (en) * | 1943-10-27 | 1950-12-05 | John D Ferry | Fibrin clots and methods for preparing the same |
US2576006A (en) * | 1947-11-29 | 1951-11-20 | Research Corp | Methods of forming shaped fibrin products |
US3523807A (en) * | 1966-11-25 | 1970-08-11 | Mihaly Gerendas | Method of making a cross-linked fibrin prosthesis |
US3641240A (en) * | 1968-09-27 | 1972-02-08 | Wyandotte Chemicals Corp | Method for the treatment of an embolus or thrombus |
US3723244A (en) * | 1971-01-18 | 1973-03-27 | Atomic Energy Commission | Fibrous fibrin sheet and method for producing same |
SE452109B (en) * | 1973-01-29 | 1987-11-16 | Pharmacia Ab | SCIENTIFIC CLEANER EXTENDED SARYTOR |
US4537767A (en) * | 1973-01-29 | 1985-08-27 | Pharmacia Aktiebolag | Method for cleansing fluid discharging skin surfaces, wounds and mucous membranes and means for carrying out the method |
US4016877A (en) * | 1976-02-23 | 1977-04-12 | Avicon, Inc. | Fibrous collagen derived web having hemostatic and wound sealing properties |
US4148664A (en) * | 1976-05-10 | 1979-04-10 | Avicon, Inc. | Preparation of fibrous collagen product having hemostatic and wound sealing properties |
US4066083A (en) * | 1976-06-03 | 1978-01-03 | Pentapharm A.G. | Sterile surgical collagen product |
US4116898A (en) * | 1977-01-31 | 1978-09-26 | Becton, Dickinson And Company | Non-thrombogenic articles |
US4225480A (en) * | 1977-02-23 | 1980-09-30 | Ppg Industries, Inc. | Addition interpolymers having improved stability and two-package compositions comprising such interpolymers and polyepoxides |
US4238480A (en) * | 1978-05-19 | 1980-12-09 | Sawyer Philip Nicholas | Method for preparing an improved hemostatic agent and method of employing the same |
AT359652B (en) | 1979-02-15 | 1980-11-25 | Immuno Ag | METHOD FOR PRODUCING A TISSUE ADHESIVE |
US4675361A (en) * | 1980-02-29 | 1987-06-23 | Thoratec Laboratories Corp. | Polymer systems suitable for blood-contacting surfaces of a biomedical device, and methods for forming |
AT366916B (en) * | 1980-04-02 | 1982-05-25 | Immuno Ag | DEVICE FOR APPLICATING A TISSUE ADHESIVE BASED ON HUMAN OR ANIMAL PROTEINS |
EP0068149A3 (en) | 1981-06-25 | 1983-07-20 | Serapharm GmbH & Co. KG | Dry preparation containing fibrinogene, its production and use |
US4442655A (en) * | 1981-06-25 | 1984-04-17 | Serapharm Michael Stroetmann | Fibrinogen-containing dry preparation, manufacture and use thereof |
SE430218B (en) * | 1981-12-30 | 1983-10-31 | Blombaeck E G B | FILTER AND SET TO MAKE A SADANT |
EP0085166B1 (en) | 1981-12-30 | 1986-06-25 | New York Blood Center, Inc. | A filter and a process for the preparation thereof |
US4578067A (en) * | 1982-04-12 | 1986-03-25 | Alcon (Puerto Rico) Inc. | Hemostatic-adhesive, collagen dressing for severed biological surfaces |
DE3214337C2 (en) * | 1982-04-19 | 1984-04-26 | Serapharm - Michael Stroetmann, 4400 Münster | Resorbable flat material for sealing and healing wounds and processes for their manufacture |
JPS58180162A (en) * | 1982-04-19 | 1983-10-21 | 株式会社高研 | Anti-thrombosis medical material |
US4463875A (en) * | 1982-06-14 | 1984-08-07 | Robert W. Mann | Method and apparatus for preparing and applying a two-component cement |
DE3234084A1 (en) | 1982-09-14 | 1984-03-15 | B. Braun Melsungen Ag, 3508 Melsungen | PHARMACEUTICAL PREPARATIONS FOR TREATING UNWANTED GROWTHS AND THEIR USE |
CH657980A5 (en) * | 1982-10-21 | 1986-10-15 | Sulzer Ag | DISPOSABLE BONE CEMENT SYRINGE. |
DE3248188A1 (en) * | 1982-12-27 | 1984-06-28 | Behringwerke Ag, 3550 Marburg | METHOD FOR PRODUCING A COLLAGEN FLEECE |
US4548736A (en) * | 1983-08-29 | 1985-10-22 | Wisconsin Alumni Research Foundation | Preparation of protein films |
US4600574A (en) * | 1984-03-21 | 1986-07-15 | Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte | Method of producing a tissue adhesive |
US4837285A (en) * | 1984-03-27 | 1989-06-06 | Medimatrix | Collagen matrix beads for soft tissue repair |
AT379311B (en) * | 1984-03-29 | 1985-12-27 | Immuno Ag | DEVICE FOR APPLICATING A TISSUE ADHESIVE |
EP0166263A1 (en) | 1984-05-31 | 1986-01-02 | Green Cross Corporation | Filler composition for filling in defect or hollow portion of bone and kit or set for the preparation of the filler composition |
DE3441675A1 (en) * | 1984-11-15 | 1986-05-22 | L. & C. Steinmüller GmbH, 5270 Gummersbach | METHOD FOR REDUCING NO (ARROW DOWN) X (ARROW DOWN) CONTENT IN COMBUSTION GASES |
DE3443167C2 (en) | 1984-11-27 | 1986-12-18 | orthoplant Endoprothetik GmbH, 2800 Bremen | Surgical cement syringe |
US4600533A (en) * | 1984-12-24 | 1986-07-15 | Collagen Corporation | Collagen membranes for medical use |
US5223420A (en) * | 1985-03-01 | 1993-06-29 | Institut National De La Sante Et De La Recherche Medicale | Elastin-based product, a procedure for its preparation and its biological applications; in particular as biomaterials and artificial supports |
WO1986007541A1 (en) * | 1985-06-19 | 1986-12-31 | Yasushi Zyo | Composition which can impart antithrombotic ability and medical apparatus to be in contact with blood |
US4690684A (en) * | 1985-07-12 | 1987-09-01 | C. R. Bard, Inc. | Meltable stent for anastomosis |
JPS6229532A (en) * | 1985-07-31 | 1987-02-07 | Koken:Kk | Antithrombogenetic medical material and production thereof |
US5002551A (en) | 1985-08-22 | 1991-03-26 | Johnson & Johnson Medical, Inc. | Method and material for prevention of surgical adhesions |
US4751921A (en) * | 1985-10-21 | 1988-06-21 | University Of Iowa Research Foundation | Bone cement syringe |
US5049393A (en) * | 1986-01-07 | 1991-09-17 | Baylor College Of Medicine | Anti-thrombogenic elastomer and objects and prostheses made therefrom |
DE3609672A1 (en) * | 1986-03-21 | 1987-09-24 | Klaus Draenert | EVACUABLE BONE CEMENT SYRINGE |
US4720512A (en) * | 1986-03-24 | 1988-01-19 | Becton, Dickinson And Company | Polymeric articles having enhanced antithrombogenic activity |
US4786556A (en) * | 1986-03-24 | 1988-11-22 | Becton, Dickinson And Company | Polymeric articles having enhanced antithrombogenic activity |
US4760131A (en) * | 1986-04-23 | 1988-07-26 | Collagen Corporation | Wound-healing composition |
US4743229A (en) * | 1986-09-29 | 1988-05-10 | Collagen Corporation | Collagen/mineral mixing device and method |
US4840626A (en) | 1986-09-29 | 1989-06-20 | Johnson & Johnson Patient Care, Inc. | Heparin-containing adhesion prevention barrier and process |
DE3722904A1 (en) * | 1987-01-09 | 1988-07-21 | Harald Maslanka | INJECTION DEVICE WITH DOUBLE CANNULA FOR AN ENDOSCOPE |
US5080893A (en) * | 1988-05-31 | 1992-01-14 | University Of Florida | Method for preventing surgical adhesions using a dilute solution of polymer |
US5244799A (en) * | 1987-05-20 | 1993-09-14 | Anderson David M | Preparation of a polymeric hydrogel containing micropores and macropores for use as a cell culture substrate |
US4882148A (en) * | 1987-06-18 | 1989-11-21 | Corvita Corporation | Crack prevention and improved thrombogenicity of implanted prostheses by sulfonation |
DE3874440T2 (en) * | 1987-07-14 | 1993-01-28 | Sankyo Co | COMPOSITION FOR PRODUCING ANTITHROMBOTIC MEDICAL PRODUCTS. |
US5260420A (en) * | 1987-07-30 | 1993-11-09 | Centre Regional De Transfusion Sanguine De Lille | Concentrate of thrombin coagulable proteins, the method of obtaining same and therapeutical use thereof |
US4978336A (en) * | 1987-09-29 | 1990-12-18 | Hemaedics, Inc. | Biological syringe system |
US5364622A (en) | 1987-12-04 | 1994-11-15 | Dr. Karl Thomae Gmbh | Methods for preventing adhesions to organs and parts of organs by application of tissue plasminogen activator and hydroxyethylcellulose hydrogel |
US5201745A (en) * | 1988-03-15 | 1993-04-13 | Imedex | Visceral surgery patch |
AT397203B (en) * | 1988-05-31 | 1994-02-25 | Immuno Ag | FABRIC ADHESIVE |
US5140016A (en) * | 1988-05-31 | 1992-08-18 | University Of Florida | Method and composition for preventing surgical adhesions using a dilute solution of polymer |
US5182317A (en) * | 1988-06-08 | 1993-01-26 | Cardiopulmonics, Inc. | Multifunctional thrombo-resistant coatings and methods of manufacture |
US4874368A (en) * | 1988-07-25 | 1989-10-17 | Micromedics, Inc. | Fibrin glue delivery system |
US4948540A (en) * | 1988-08-01 | 1990-08-14 | Semex Medical, Inc. | Method of preparing collagen dressing sheet material |
US5167960A (en) * | 1988-08-03 | 1992-12-01 | New England Deaconess Hospital Corporation | Hirudin-coated biocompatible substance |
US5112615A (en) * | 1988-08-03 | 1992-05-12 | New England Deaconess Hospital Corporation | Soluble hirudin conjugates |
US5019393A (en) * | 1988-08-03 | 1991-05-28 | New England Deaconess Hospital Corporation | Biocompatible substance with thromboresistance |
US5126140A (en) * | 1988-08-03 | 1992-06-30 | New England Deaconess Hospital Corporation | Thrombomodulin-coated bicompatible substance |
US5213580A (en) * | 1988-08-24 | 1993-05-25 | Endoluminal Therapeutics, Inc. | Biodegradable polymeric endoluminal sealing process |
US5053048A (en) * | 1988-09-22 | 1991-10-01 | Cordis Corporation | Thromboresistant coating |
US4911926A (en) * | 1988-11-16 | 1990-03-27 | Mediventures Inc. | Method and composition for reducing postsurgical adhesions |
ZA899326B (en) | 1988-12-07 | 1991-08-28 | Johnson & Johnson Patient Care | Low molecular weight heparin,heparinoid and hexuronyl hexosaminoglycan sulfate containing adhesion prevention barrier and process |
DE3841397A1 (en) | 1988-12-08 | 1990-06-21 | Melzer Wolfgang | Porous absorbable medicinal substance carrier |
DK235589D0 (en) | 1989-05-12 | 1989-05-12 | Wolff & Kaaber | METHOD AND APPARATUS FOR MIXING A SOLID AND LIQUID COMPONENT |
US5116315A (en) * | 1989-10-03 | 1992-05-26 | Hemaedics, Inc. | Biological syringe system |
US5071664A (en) * | 1989-10-20 | 1991-12-10 | Brown Sand T | Method of removing sulfites from standard wine |
US5525348A (en) | 1989-11-02 | 1996-06-11 | Sts Biopolymers, Inc. | Coating compositions comprising pharmaceutical agents |
US5318524A (en) | 1990-01-03 | 1994-06-07 | Cryolife, Inc. | Fibrin sealant delivery kit |
US5209745A (en) * | 1990-02-06 | 1993-05-11 | Irr Joseph D | Blood cryopreservation container |
WO1991017724A1 (en) | 1990-05-17 | 1991-11-28 | Harbor Medical Devices, Inc. | Medical device polymer |
US5455040A (en) | 1990-07-26 | 1995-10-03 | Case Western Reserve University | Anticoagulant plasma polymer-modified substrate |
US5209776A (en) * | 1990-07-27 | 1993-05-11 | The Trustees Of Columbia University In The City Of New York | Tissue bonding and sealing composition and method of using the same |
US5292362A (en) * | 1990-07-27 | 1994-03-08 | The Trustees Of Columbia University In The City Of New York | Tissue bonding and sealing composition and method of using the same |
US5071644A (en) | 1990-08-07 | 1991-12-10 | Mediventures, Inc. | Topical drug delivery with thermo-irreversible gels |
DE9011685U1 (en) * | 1990-08-10 | 1991-12-12 | Thera Patent Gmbh & Co. Kg Gesellschaft Fuer Industrielle Schutzrechte, 8031 Seefeld, De | |
US5486357A (en) | 1990-11-08 | 1996-01-23 | Cordis Corporation | Radiofrequency plasma biocompatibility treatment of inside surfaces |
DK288590D0 (en) * | 1990-12-04 | 1990-12-04 | Michael Morris | MIXTURE / SOLUTION SPRAY FOR CYTOSTATICS FOR MEDICAL TREATMENT OF CANCER PATIENTS |
EP0495478B1 (en) | 1991-01-16 | 1999-04-21 | Toyo Boseki Kabushiki Kaisha | A material compatible with blood |
US5156613A (en) * | 1991-02-13 | 1992-10-20 | Interface Biomedical Laboratories Corp. | Collagen welding rod material for use in tissue welding |
JP2858045B2 (en) | 1991-05-31 | 1999-02-17 | バクスター インターナショナル インコーポレーテッド | Anticoagulant coating for defoaming applications |
JPH06500802A (en) | 1991-06-14 | 1994-01-27 | アムジエン・インコーポレーテツド | Protein drug delivery using collagen film |
US5144799A (en) * | 1991-07-18 | 1992-09-08 | Barth Randolph S | Crossfire calibrated exhaust system |
FR2679778B1 (en) | 1991-08-02 | 1995-07-07 | Coletica | USE OF CROLAGEN CROSSLINKED BY A CROSSLINKING AGENT FOR THE MANUFACTURE OF A SLOW RESORPTIVE, BIOCOMPATIBLE, SUTURABLE MEMBRANE, AS WELL AS SUCH A MEMBRANE. |
US5368563A (en) | 1991-12-18 | 1994-11-29 | Micromedics, Inc. | Sprayer assembly for physiologic glue |
US5376376A (en) | 1992-01-13 | 1994-12-27 | Li; Shu-Tung | Resorbable vascular wound dressings |
US5272074A (en) | 1992-04-23 | 1993-12-21 | Mcmaster University | Fibrin coated polymer surfaces |
US5376692A (en) | 1992-05-15 | 1994-12-27 | Purdue Research Foundation | Method of binding using irradiation and product with albumin bound to biomaterials |
DE4219563A1 (en) * | 1992-06-15 | 1993-12-16 | Draenert Klaus | Application system |
FR2692582B1 (en) | 1992-06-18 | 1998-09-18 | Flamel Tech Sa | NEW CROSSLINKABLE DERIVATIVES OF COLLAGEN, THEIR PROCESS FOR OBTAINING IT AND THEIR APPLICATION TO THE PREPARATION OF BIOMATERIALS. |
DE69324004T3 (en) | 1992-09-26 | 2005-09-01 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | APPLICATOR FOR TISSUE ADHESIVE |
US5278200A (en) * | 1992-10-30 | 1994-01-11 | Medtronic, Inc. | Thromboresistant material and articles |
US5397816A (en) | 1992-11-17 | 1995-03-14 | Ethicon, Inc. | Reinforced absorbable polymers |
DE4304716A1 (en) | 1993-02-16 | 1994-08-18 | Melzer Wolfgang | Delayed-release topical drug |
US5395923A (en) | 1993-02-23 | 1995-03-07 | Haemacure-Biotech, Inc. | Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out" |
AT400675B (en) | 1993-10-18 | 1996-02-26 | Immuno Ag | SYRINGE SET FOR STORAGE AND APPLICATION OF A MULTI-COMPONENT MATERIAL, SYRINGE DEVICE AND ACTUATING DEVICE THEREFOR, AND METHOD FOR PRODUCING A FILLED, STERILE SYRINGE DEVICE |
US6241734B1 (en) * | 1998-08-14 | 2001-06-05 | Kyphon, Inc. | Systems and methods for placing materials into bone |
US5522804A (en) * | 1994-02-15 | 1996-06-04 | Lynn; Lawrence A. | Aspiration, mixing, and injection syringe |
AT400304B (en) | 1994-02-28 | 1995-12-27 | Immuno Ag | DEVICE FOR APPLICATING A MULTI-COMPONENT TISSUE ADHESIVE |
US5578073A (en) | 1994-09-16 | 1996-11-26 | Ramot Of Tel Aviv University | Thromboresistant surface treatment for biomaterials |
DE4445969C1 (en) * | 1994-12-22 | 1996-03-14 | Schott Glaswerke | Syringe cylinder with two compartments for two constituents |
AU697045B2 (en) | 1995-01-16 | 1998-09-24 | Baxter International Inc. | Self-supporting sheet-like material of cross-linked fibrin for preventing post- operative adhesions |
US6599515B1 (en) * | 1995-01-16 | 2003-07-29 | Baxter International Inc. | Fibrin porous structure |
US6965014B1 (en) * | 1996-01-16 | 2005-11-15 | Baxter International Inc. | Fibrin material and method for producing and using the same |
US20020131933A1 (en) * | 1996-01-16 | 2002-09-19 | Yves Delmotte | Biopolymer membrane and methods for its preparation |
US5580923A (en) | 1995-03-14 | 1996-12-03 | Collagen Corporation | Anti-adhesion films and compositions for medical use |
US5785682A (en) * | 1995-03-22 | 1998-07-28 | Abbott Laboratories | Pre-filled syringe drug delivery system |
US5779668A (en) * | 1995-03-29 | 1998-07-14 | Abbott Laboratories | Syringe barrel for lyophilization, reconstitution and administration |
US6409972B1 (en) | 1995-06-06 | 2002-06-25 | Kwan-Ho Chan | Prepackaged liquid bone cement |
US5697903A (en) | 1996-02-22 | 1997-12-16 | Ultradent Products, Inc. | Methods and apparatus for dispensing compositions |
EP0917444A1 (en) | 1996-07-12 | 1999-05-26 | Baxter Travenol Laboratories, Inc. | A fibrin delivery device and method for forming fibrin on a surface |
US5844087A (en) | 1996-11-05 | 1998-12-01 | Bayer Corporation | Method and device for delivering fibrin glue |
US6613020B1 (en) | 1996-12-06 | 2003-09-02 | Bristol-Myers Squibb Company | Method of applying a mixture of two liquid components as well as a device for carrying out the method |
US6554803B1 (en) * | 1997-04-02 | 2003-04-29 | Arthur Ashman | Combination syringe and aspirator for bone regeneration material and method for using the syringe |
US20020119417A1 (en) * | 1998-05-29 | 2002-08-29 | Arthur Ashman | Nozzle tip for use with syringe and method for using same |
US6331172B1 (en) | 1997-04-14 | 2001-12-18 | Baxter International Inc. | Applicator for dispensing measured quantities with use of controlled suction |
AU7425598A (en) * | 1997-05-21 | 2000-01-10 | Nikomed Aps | An apparatus for preparing bone cement |
ES2227861T3 (en) * | 1997-07-11 | 2005-04-01 | United States Surgical Corporation | FIBRINE TAIL APPLICATOR SYSTEM. |
US5910315A (en) | 1997-07-18 | 1999-06-08 | Stevenson; Sharon | Allograft tissue material for filling spinal fusion cages or related surgical spaces |
US6780411B2 (en) * | 1998-05-01 | 2004-08-24 | Zymogenetics, Inc. | Tissue sealant compositions |
US6461361B1 (en) | 1998-05-01 | 2002-10-08 | Baxter International Inc. | Gas-driven spraying of mixed sealant agents |
JP2002515309A (en) * | 1998-05-21 | 2002-05-28 | バクスター・インターナショナル・インコーポレイテッド | Method of using sealant applicator and impact cleaning |
US6475183B1 (en) | 1998-06-03 | 2002-11-05 | Baxter International Inc. | Direct dual filling device for sealing agents |
US6471670B1 (en) | 1998-10-05 | 2002-10-29 | Karl Enrenfels | Fibrin sealant applicator system |
US6086594A (en) * | 1998-10-16 | 2000-07-11 | Brown; Byron L. | Cement pressurizing device |
JP4889861B2 (en) * | 1998-11-18 | 2012-03-07 | ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー | Stabilized protein preparation for tissue adhesives |
US6551334B2 (en) * | 1999-04-16 | 2003-04-22 | Integrated Vascular Interventional Technologies, Lc | Externally directed anastomosis systems and externally positioned anastomosis fenestra cutting apparatus |
WO2000072857A1 (en) * | 1999-06-01 | 2000-12-07 | Bristol-Myers Squibb Company | Fibrin polymer structure |
US6491201B1 (en) | 2000-02-22 | 2002-12-10 | Power Medical Interventions, Inc. | Fluid delivery mechanism for use with anastomosing, stapling, and resecting instruments |
DE19956503A1 (en) * | 1999-11-24 | 2001-06-21 | Universitaetsklinikum Freiburg | Sprayable bone replacement material |
US6425885B1 (en) * | 1999-12-20 | 2002-07-30 | Ultradent Products, Inc. | Hydraulic syringe |
US6566345B2 (en) * | 2000-04-28 | 2003-05-20 | Fziomed, Inc. | Polyacid/polyalkylene oxide foams and gels and methods for their delivery |
US20010037091A1 (en) * | 1999-12-29 | 2001-11-01 | Wironen John F. | System for reconstituting pastes and methods of using same |
EP1118313B1 (en) | 2000-01-18 | 2005-02-23 | Zimmer GmbH | Gun for squeezing out bone cement with a mountable cement syringe |
DE50009584D1 (en) * | 2000-01-18 | 2005-03-31 | Zimmer Gmbh Winterthur | Pistol for pressing out bone cement with an attachable cement syringe |
WO2001056515A2 (en) * | 2000-02-04 | 2001-08-09 | Regeneration Technologies, Inc. | Methods and kit for injecting materials into bone |
US6488197B1 (en) | 2000-02-22 | 2002-12-03 | Power Medical Interventions, Inc. | Fluid delivery device for use with anastomosing resecting and stapling instruments |
US6406175B1 (en) * | 2000-05-04 | 2002-06-18 | James F. Marino | Bone cement isovolumic mixing and injection device |
JP2001340356A (en) * | 2000-05-31 | 2001-12-11 | Gc Corp | Capsule for tooth restoring material |
WO2002034148A2 (en) * | 2000-10-25 | 2002-05-02 | Kyphon Inc. | Systems and methods for reducing fractured bone using a fracture reduction cannula |
DE10057616B4 (en) * | 2000-11-21 | 2006-09-14 | Stryker Trauma Gmbh | Method for mixing and applying flowable bone cement and bone cement mixing device |
US6592251B2 (en) * | 2001-01-26 | 2003-07-15 | Howmedica Osteonics Corp. | Cement mixing and dispensing device |
US6723131B2 (en) | 2001-02-28 | 2004-04-20 | The Cleveland Clinic Foundation | Composite bone marrow graft material with method and kit |
US20020139088A1 (en) | 2001-03-08 | 2002-10-03 | Archie Woodworth | Polymeric syringe body and stopper |
US6676663B2 (en) * | 2001-07-19 | 2004-01-13 | Higueras Antonio Perez | Applicator device for controllably injecting a surgical cement into bones |
US6972168B2 (en) * | 2001-08-13 | 2005-12-06 | University Of Florida Research Foundation, Incorporated | Materials and methods for nerve grafting, selection of nerve grafts, and in vitro nerve tissue culture |
US6793660B2 (en) * | 2001-08-20 | 2004-09-21 | Synthes (U.S.A.) | Threaded syringe for delivery of a bone substitute material |
US6712794B2 (en) * | 2001-08-21 | 2004-03-30 | Spinal Specialties, Inc. | Apparatus for delivering a viscous liquid to a surgical site |
US7488320B2 (en) * | 2001-11-01 | 2009-02-10 | Renova Orthopedics, Llc | Orthopaedic implant fixation using an in-situ formed anchor |
US7247288B2 (en) * | 2002-04-18 | 2007-07-24 | Carnegie Mellon University | Method of manufacturing hydroxyapatite and uses therefor in delivery of nucleic acids |
CA2536188A1 (en) * | 2003-11-20 | 2005-06-09 | Angiotech International Ag | Electrical devices and anti-scarring agents |
-
2002
- 2002-10-04 US US10/265,076 patent/US7135027B2/en not_active Expired - Lifetime
-
2003
- 2003-10-03 WO PCT/US2003/031691 patent/WO2004032808A2/en not_active Application Discontinuation
- 2003-10-03 AU AU2003275463A patent/AU2003275463A1/en not_active Abandoned
- 2003-10-03 DE DE60329307T patent/DE60329307D1/en not_active Expired - Lifetime
- 2003-10-03 EP EP20030759741 patent/EP1545403B1/en not_active Expired - Lifetime
-
2006
- 2006-11-02 US US11/555,942 patent/US7766919B2/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4061787A (en) | 1976-03-15 | 1977-12-06 | Union Carbide Corporation | Collagen compositions having crosslinking agent incorporated therein and the method of preparing the same |
US5643464A (en) | 1988-11-21 | 1997-07-01 | Collagen Corporation | Process for preparing a sterile, dry crosslinking agent |
US6007613A (en) | 1994-11-03 | 1999-12-28 | Fusion Medical Technologies, Inc. | Bioadhesive; preparation procedure and device for the application of a bioadhesive; and hardeners for a bioadhesive |
US6165489A (en) | 1994-11-23 | 2000-12-26 | Cohesion Technologies, Inc. | Crosslinked collagen compositions for in situ administration |
US6063061A (en) | 1996-08-27 | 2000-05-16 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
US6066325A (en) | 1996-08-27 | 2000-05-23 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
US6395307B1 (en) | 1997-04-30 | 2002-05-28 | Reckitt Benckiser (Uk) Limited | Pourable alginate compositions |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7713303B2 (en) | 2002-09-18 | 2010-05-11 | Warsaw Orthopedic, Inc. | Collagen-based materials and methods for augmenting intervertebral discs |
US7744651B2 (en) | 2002-09-18 | 2010-06-29 | Warsaw Orthopedic, Inc | Compositions and methods for treating intervertebral discs with collagen-based materials |
US7731981B2 (en) | 2002-11-15 | 2010-06-08 | Warsaw Orthopedic, Inc. | Collagen-based materials and methods for treating synovial joints |
WO2006128564A1 (en) * | 2005-05-31 | 2006-12-07 | Baxter International Inc. | Polypropylene hollow barrel with sliding coated rubber piston |
US8118779B2 (en) | 2006-06-30 | 2012-02-21 | Warsaw Orthopedic, Inc. | Collagen delivery device |
US8399619B2 (en) | 2006-06-30 | 2013-03-19 | Warsaw Orthopedic, Inc. | Injectable collagen material |
DE202013010100U1 (en) * | 2013-11-07 | 2015-02-09 | Mathys Ag Bettlach | Dosing device for filling Appliziervorrichtungen with bone cement or bone replacement pastes |
TWI705811B (en) * | 2015-06-19 | 2020-10-01 | 美商巴克斯歐塔公司 | Pooling device for single or multiple medical containers |
US11219578B2 (en) | 2015-06-19 | 2022-01-11 | Takeda Pharmaceutical Company Limited | Pooling device for single or multiple medical containers |
TWI783262B (en) * | 2015-06-19 | 2022-11-11 | 日商武田藥品工業股份有限公司 | Device for pooling a medicinal fluid and method of operating a device for pooling a medicinal fluid |
US11684548B2 (en) | 2015-06-19 | 2023-06-27 | Takeda Pharmaceutical Company Limited | Pooling device for single or multiple medical containers |
US11903900B2 (en) | 2018-10-03 | 2024-02-20 | Takeda Pharmaceutical Company Limited | Packaging for multiple containers |
Also Published As
Publication number | Publication date |
---|---|
US7135027B2 (en) | 2006-11-14 |
US7766919B2 (en) | 2010-08-03 |
AU2003275463A1 (en) | 2004-05-04 |
US20040068266A1 (en) | 2004-04-08 |
US20080109002A1 (en) | 2008-05-08 |
AU2003275463A8 (en) | 2004-05-04 |
WO2004032808A3 (en) | 2004-08-19 |
EP1545403A2 (en) | 2005-06-29 |
EP1545403B1 (en) | 2009-09-16 |
DE60329307D1 (en) | 2009-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7135027B2 (en) | Devices and methods for mixing and extruding medically useful compositions | |
US10441683B2 (en) | Method for restoring bone using shapeable bone graft substitute and instruments for delivery thereof | |
US5650108A (en) | Porous bone replacement materials | |
CA2438192C (en) | System for reconstituting pastes and methods of using same | |
EP2200523B1 (en) | Bone cement mixing and delivery system and methods of use thereof | |
EP3072538B1 (en) | Bioactive flowable wash-out resistant bone graft material and method for production thereof | |
US7052517B2 (en) | Delivery device for biological composites and method of preparation thereof | |
KR20020082231A (en) | Shaped Particle and Composition for Bone Deficiency and Method of Making the Particle | |
WO2001085225A2 (en) | Fibrin porous structure | |
JPH0360501B2 (en) | ||
US20230364305A1 (en) | Injectable calcium phosphate-based bone graft composition having high elasticity and preparation method thereof | |
JP2004073849A (en) | Globular calcium phosphate coated with biodegradable plastic and its application | |
WO2002040963A2 (en) | Biologically active composites and methods for their production and use | |
WO2022182692A1 (en) | Injectable tissue repair devices and processes for preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003759741 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003759741 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |